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ABSTRACT OF THE DISSERTATION 
Growth Factor Gradient Formation and Release from  
PEG Microspheres for Nerve Regeneration. 
By Jacob Levi Roam 
Doctor of Philosophy in Biomedical Engineering 
Washington University in St. Louis, 2015 
Professor Donald Elbert, Chair 
 
 Many biological processes depend on concentration gradients in signaling molecules. 
Thus, introduction of spatial patterning of proteins, while retaining activity and releasability, will 
be critical for the field of regenerative medicine.  In particular, the area of nerve regeneration is 
in need of innovations to improve outcomes.  Only about 25% of surgical patients with 
peripheral nerve damage (~200,000 surgical interventions performed each year) regain full motor 
function with less than 3% regaining sensation.  The use of nerve guidance conduits (NGC’s) 
which are filled with biomimetic scaffolds is one treatment being explored. These scaffolds, 
however, lack the spatial patterning of proteins found in native tissue.  Glial-cell line derived 
neurotrophic factor (GDNF), a potent stimulator of axon regeneration, is one such protein that, if 
contained within the scaffold and conformed to a particular concentration profile, could greatly 
enhance neural regeneration. The object of this work is to utilize poly(ethylene glycol) (PEG) 
microspheres to accomplish this spatial patterning of GDNF and apply it to NGC’s. 
 First, an approach utilizing the controllability of the PEG microsphere’s density 
(buoyancy) was explored. By creating the microspheres under varying conditions, incubation 
time and temperature, the cross-linking and, thus, the swelling rate of the microspheres could be 
xii 
 
controlled.  This created microspheres of different densities that, upon centrifugation, would 
orient themselves within a scaffold, creating a gradient in the different microsphere types.  
GDNF loaded into a batch of microspheres would thusly be oriented within the scaffold along 
with that particular microsphere batch. Through this, gradients in GDNF were created. Heparin 
was also added to the microspheres to allow for reversible binding of GDNF.   
 Next, gradients in reversibly bound GDNF were formed through sequential centrifugation 
of microsphere batches. For instance, a layer of GDNF loaded microspheres were formed into a 
scaffold followed by a layer of microspheres without GDNF on top of them.  This created an 
initial step gradient in GDNF that, given time to release, would form a linear concentration 
gradient.  Gradients formed by this method were visualized by fluorescent confocal microscopy 
and compared to Fickian models. Some conditions yielded profiles more linear than the model 
predictions, which persisted for over a week.  
 Lastly, the sequential gradient formation was modified and applied to NGC’s.  Before the 
scaffolds were ready for in vivo implantation, functionalities such as cell initiated degradability, 
cell adhesion, and inter-microsphere cross-linking were added.  A plasmin degradable peptide 
sequence (GCGGVRNGGK) was incorporated into the microspheres. CLICK agents, laminin, 
and heparin (via a new binding chemistry) were attached to the microspheres to add inter-
microsphere cross-linking, add cell adhesion, and heparin binding functionalities, respectively. 
GDNF gradient formation and activity retention were confirmed with these fully functionalized 
microspheres. Microsphere scaffolds with linear gradients in GDNF were then formed in silicone 
tubes which were transplanted into rats with severed sciatic nerves. 
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Chapter 1  
 
Introduction  
 
1.1 Synopsis and Objectives of Thesis 
 
 The primary objective of this work is to create functional nerve guidance conduits (NGC’s) 
containing poly(ethylene glycol) microspheres incorporating a linear concentration gradient in glial 
cell-derived neurotrophic factor (GDNF).  Concentration gradients of signaling molecules are 
important in wound healing, as well as embryogenesis, immunity, angiogenesis, and nerve cell 
signaling (X. Cao & Shoichet, 2001; Parent & Devreotes, 1999; Singh, Morris, Ellis, Detamore, & 
Berkland, 2008; H. Song  & Poo , 2001). In particular, chemotaxis, the preferential movement of cells 
up a concentration gradient of signaling molecules, is known to be dependent upon the steepness of a 
concentration gradient as opposed to the average concentration of the molecule (Knapp, Helou, & 
Tranquillo, 1999; K. Moore, MacSween, & Shoichet, 2006; Parent & Devreotes, 1999). Utilization of 
such gradients may be critical to the advancement of nerve regeneration. Because scaffolds formed 
from hydrogels made of synthetic polymers show significant promise in regenerative medicine (Drury 
& Mooney, 2003; E. a. Scott, Nichols, Kuntz-Willits, & Elbert, 2010; Tessmar & Göpferich, 2007), 
this research sought to create gradients with PEG microsphere scaffolds. Because these microsphere 
scaffolds are formed in a modular manner (Nichols, Scott, & Elbert, 2009; E. a. Scott et al., 2010), 
distinct disadvantages, such as scaling issues and difficulty in pumping polymerizing solutions (X. 
Cao & Shoichet, 2001; Kapur & Shoichet, 2004; Knapp et al., 1999; H. Song  & Poo , 2001), incurred 
by other gradient making systems can be circumvented (Rivest et al., 2007; E. a. Scott et al., 2010; 
Serban & Prestwich, 2008).  
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 This work details two approaches to this problem. First, microspheres of varying densities 
(buoyancies) were fabricated which, upon centrifugation would orient themselves into scaffold 
containing a gradient in microspheres (Roam, Xu, Nguyen, & Elbert, 2010). The density (buoyancy) 
of the microspheres could be altered via their cross-link density which is controllable by varying 
incubation times and temperatures at microsphere formation (Nichols et al., 2009). Proteins such as 
protamine and GDNF were bonded to the microspheres which were then mixed with microsphere of 
different densities containing no bond protein. After centrifugation and microsphere scaffold 
formation, gradients in these proteins were observed. In order to avoid damage to the GDNF 
potentially caused by the covalent bonding and to maintain releasability, the study sought to use 
heparin, which promotes electrostatic (reversible) binding of heparin-binding proteins (Nie, Baldwin, 
Yamaguchi, & Kiick, 2007; Sakiyama-Elbert & Hubbell, 2000; Tae, Scatena, Stayton, & Hoffman, 
2006). Heparin was incorporated into the microspheres via an EDC/NHS activation of carboxylic 
acids (Tae et al., 2006), and gradients in reversibly bound protamine and GDNF were formed. 
 The second approach, which eliminated much of the complexity and variability of the first 
approach, was to centrifuge different batches of microspheres sequentially in order to form distinct 
layers (Roam, Nguyen, & Elbert, 2014).  GDNF electrostatically bound into one of the layers by 
heparin would slowly release from that layer into the unoccupied layer, forming a gradient.  The 
gradients were tracked over time by fluorescent confocal microscopy and compared to predictions by 
fickian models. In some cases, particularly the simple two-tier initial step gradient, this system 
formed gradients more linear than the predictions and maintained them for over a week.  This success 
led to the third portion of this work which sought to implement this second gradient making system 
within NGC’s. 
 Before the scaffolds were ready for in vivo testing, however, certain functionalities needed to 
be added to the microspheres. Cell initiated degradability, inter-microsphere cross-linking, and cell 
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adhesion needed to be incorporated into the microsphere in order for the scaffolds to be functional for 
nerve regeneration. While cell initiated degradability will be necessary simply to make room in the 
conduit for the extending nerve, replication the native degradability of natural biomaterials, such as 
fibrin, has the added benefit of stimulating the regeneration process (Ehrbar et al., 2007; M P Lutolf 
& Hubbell, 2005).  This study implemented peptide sequences sensitive to plasmin, a second enzyme 
that plays a key role in cell migration, especially during wound healing (West & Hubbell, 1999). To 
promote scaffold stability, it will be necessary for the microspheres to cross-link to one another.  In 
order to accomplish this under physiological conditions without using agents that might interact with 
the GDNF, other ambient proteins, or the extending nerves themselves, this study utilized 
bioorthogonal Click reactions (Nwe & Brechbiel, 2009).  Click agents had already been attached to 
the Elbert lab’s PEG microspheres (Nguyen, Snyder, Shields, Smith, & Elbert, 2013).  To allow 
extending nerves to attach to and subsequently grow through our scaffold, laminin, a basement 
membrane protein that influences cell adhesion,  neurite outgrowth,  growth cone movement, and acts 
as a neuronal cue (Culley et al., 2001; Evans et al., 2007; Swindle-Reilly et al., 2012), was attached to 
the microspheres. The gradient making capability of scaffold made from these fully functionalized 
microspheres was confirmed, and the GDNF released by them was verified to have maintained its 
activity.  Finally, NGC’s containing scaffolds made from these fully functionalized microspheres and 
gradients in GDNF were implanted into rats with severed sciatic nerves. 
 The following introduction will highlight the key principles that support this thesis work 
regarding synthetic biomaterials and peripheral nerve injury. Current research involving the design of 
biomaterial scaffolds and delivery of growth factors will be discussed. 
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1.2 Biological Gradients 
 It has long been known that concentration gradients in biological molecules are crucial to the 
guidance of cells (Fisher, Merkl, & Gerisch, 1989; Parent & Devreotes, 1999). Cells rely on 
directional sensing to determine the direction and proximity of extracellular stimuli, whether chemical 
or topographical, that control differentiation, survival, and proliferation and direct cell migration.  
Chemotaxis, immunity, angiogenesis, wound healing, embryogenesis, neuronal patterning, and many 
other processes are critically dependent upon this directionality, and the sensing of gradients is one 
important way cells are able to gather this information. Cells react to chemoattractants by a number of 
means including G protein–linked signaling pathways and activation of the Rho family of small 
guanosine trisphosphatases (GTPases) to induce actin polymerization (Parent & Devreotes, 1999). 
Concentration differences as low as 2% between the front and the back of the cell can be detected, 
and, thus, the relative steepness of a gradient rather than the mean concentration of a molecule will 
heavily affect the actions of a cell (Tranquillo, 1988). 
1.2.1 Gradients and Nerves 
 Chemical gradients are also critical to neuronal guidance.  More than a century ago, Cajal 
suggested that the migration of neuroblasts and growth cones might be guided by gradients of 
chemical substances secreted by the target cells (Cajal, 1995).  Micropipettes containing NGF placed 
near growing chick dorsal root ganglia (DRG) allowed the NGF to diffuse out, creating a gradient and 
directing the extending neurites from the DRG to the micropipette (Gundersen & Barrett, 1979). 
Song, et al, found that gradients of brain-derived neurotrophic factor (BDNF) can trigger an attractive 
turning response of the growth cone of Xenopus spinal neurons in vitro (H. Song  & Poo , 2001; H. J. 
Song, Ming, & Poo, 1997). The Shoichet lab has shown that growing PC12 exposed to a gradient in 
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nerve growth factor (NGF) will orient themselves in the direction of that gradient (X. Cao & 
Shoichet, 2001).  A later study by the same lab showed that PC12 cells would extend neurites up a 
gradient of immobilized NGF (Kapur & Shoichet, 2004).   These studies show the potential for 
application of gradients to tissue engineering systems, especially those intended for nerve 
regeneration. Specifically engineered gradients in neuronal cues could be critical for the advancement 
of peripheral nerve injury treatment therapies. 
1.2.2 Strategies for Gradient Fabrication 
 A number of systems currently exist for fabricating growth factor concentration gradients. On 
the microscopic scale, chemical gradients can be formed around single cells, or very small colonies, 
through the pulsatile application of picoliters of a growth factor solution near the cell (Parent & 
Devreotes, 1999; H. Song  & Poo , 2001; H. J. Song et al., 1997).  This is extremely small scale, only 
useful for single-cell level experimentation and not really suitable for in vivo experimentation, or 
clinical treatments.  The most widely used form of gradient creation is simple diffusion of a molecule 
into a gel.  A pre-loaded gel can be allowed to release in one direction, forming the gradient, or one 
side of a gel can be exposed to a solution of the desired growth factor allowing the growth factor to 
diffuse into it; from there the gel can be used as diffusion is happening, removed once diffusion into 
the gel has created a gradient, or (X. Cao & Shoichet, 2001; Dodla & Bellamkonda, 2008, 2006; X 
Yu, Dillon, & Bellamkonda, 1999).  Knapp, et al. used this method to create a gradient in chemotactic 
factor in a collagen gel that, when seeded with fibroblasts, would provide a unique assay for cell 
chemotaxis (Knapp et al., 1999).  This method, however, is lacking in robustness, as only certain 
gradient profiles can be formed, and the gradients will not persist for long once removed from the 
growth factor source, though the latter difficulty has been overcome by covalently bonding the 
growth factor into the gel after the diffusional gradient has formed (Dodla & Bellamkonda, 2006; 
6 
 
Vepari & Kaplan, 2006).  Kipper, et al also devised a unique variation on this system. By slowly 
pumping a solution containing a “coupling agent” though a fibrin gel, they ensured that different 
points in the gel would be exposed to the agent for gradually increasing times, thus having the agent 
bond to the gel in a gradient of concentrations (Kipper, Kleinman, & Wang, 2007). 
 A number of more controlled means of creating gradients have been conceived. Gradients 
have been made by modularly layering polymer scaffolds, with each layer containing different 
concentrations of the target molecule (Mapili, Lu, Chen, & Roy, 2005; Suri et al., 2011).  Printing 
techniques have allowed for the 2D patterning of molecules on a surface, making a gradient on which 
cells can be cultured (Campbell, Miller, Fisher, Walker, & Weiss, 2005; Rosoff et al., 2004).  Similar 
to the printing methods, photo-patterning has also allowed for the precise placement of molecules into 
a gradient profile (Iha et al., 2009; Stefonek & Masters, 2007).  By creating gradients in light 
exposure over the length of a scaffold with photo-reactive elements, gradients in the molecules 
captured in those reactions are formed (Deforest, Sims, & Anseth, 2010; Polizzotti, Fairbanks, & 
Anseth, 2008).  Gradients in lentiviral vector mediated GDNF production were created along a nerve 
through multiple injections of the vector in varying amounts (Eggers et al., 2013).  Oh, et al. created 
gradients of growth factors by using polycaprolactone (PCL) microfibers that, upon centrifugation 
would pack together in a gradient of densities, the top being loosely packed and the bottom being 
heavily packed (Oh, Kim, & Lee, 2011).  Davidenko, et al created a gradient in scaffold structure by 
thermal means, with a heating element placed to one side of a solution of heat-reactive constituents 
creating a temperature gradient in the solution that would cause the scaffold to form with a gradient of 
properties (Davidenko et al., 2012). 
Microfluidic devises have been employed by many groups for the fabrication of gradients 
(Khademhosseini & Langer, 2007).  By combining polymerizing solutions with varying 
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concentrations of a target molecule within microfluidic chambers, gradients can be formed in a very 
precise, controlled manner (Chung et al., 2009; Edalat, Sheu, Manoucheri, & Khademhosseini, 2012; 
J. He et al., 2010; Zaari, Rajagopalan, Kim, Engler, & Wong, 2004).  He, et al created centimeter-
long gradients in an RGD adhesion peptide within a microfluidic channel through passive-pump-
induced forward flow followed by evaporation-induced backward flow, with the hydrogel material 
containing the gradient synthesized via photopolymerization (J. He et al., 2010). Microfluidic chips 
have also been engineered, capable of producing testing platforms with precise gradient profiles in 
numerous molecules (Cosson, Kobel, & Lutolf, 2009).  This method is obviously lacking due to its 
small scale, but the process has been scaled up in the form of a device called a “gradient maker.” 
 Commercially available gradient makers are made up of the two chambers of polymerizing 
solutions, one of which containing the molecule of interest, connected by a pumping system capable 
of modulating the ratio of one solution to the other (Kapur & Shoichet, 2004).  The Shoichet group 
has used this technology extensively to make gradients in growth factors, especially nerve growth 
factor (NGF), to test the responsiveness of PC12 cells and DRG’s to gradients and to biomaterial 
scaffolds with gradients for nerve regeneration (Kapur & Shoichet, 2004; K. Moore et al., 2006).  
Other groups have used the system to similar ends, created gels with gradients and culturing cells on 
those gels to evaluate the effect of the gradient (DeLong, Moon, & West, 2005; Lühmann, Hänseler, 
Grant, & Hall, 2009).  Microspheres containing the target molecule could also be formed into a 
gradient within the greater polymer scaffold through this technology (X. Wang et al., 2009).  Scott, et 
al. used the system to create a gradient containing gel capable of sustained, zero-order release (D. C. 
Scott & Hollenbeck, 1991). This system has the distinct disadvantage of the viscous polymer 
solutions being difficult to pump, and considering in vivo applications, air bubbles and harsh 
chemicals involved in polymerization are a concern.  
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 Many of these difficulties can be overcome by creating gradient containing scaffolds by 
modular means through the use of microparticles. One method involves making microspheres, some 
of which encapsulate a growth factor, and injecting the microspheres with and without the growth 
factor into a mold at varying rates, much like the gradient maker, to form the gradient (Dormer, 
Singh, Wang, Berkland, & Detamore, 2010; Singh et al., 2008).  Scott, et al. created modular 
microsphere scaffolds with varying properties within the scaffold.  Though concentration gradients 
were not created, they theorized that their system would be very conducive to that use (E. a. Scott et 
al., 2010).  This work seeks to expand upon that idea.  
1.3 Poly(ethlyene glycol) Biomaterials  
Poly(ethylene glycol) (PEG), also referred to as poly(ethylene) oxide at high molecular 
weights, is a synthetic polymer composed of ethylene oxide monomers. Described as a “stealth 
material” and long approved by the FDA for clinical use, PEG has a general formula of HO-(CH2-
CH2-O)n-H and is strongly hydrophilic (Bailey & Koleske, 1967; Peppas, Hilt, Khademhosseini, & 
Langer, 2006).  PEG is a highly favored material for many therapeutic applications due to its 
resistance to protein adsorption and cell adhesion.  Here, I will discuss its potential as hydrogel 
scaffold for NGC’s.   
1.3.1 History of PEG materials 
Most materials implanted in vivo trigger a foreign body response caused by their adsorbtion of 
proteins from the blood over long periods of time, walling off the implant in a fibrotic capsule 
(Ratner, Hoffman, Schoen, & Lemons, 2013).  Coagulation studies in the early 1970s first reported 
PEG’s ability to prevent cell adhesion (George, 1972).  Not long after, it was demonstrated that 
protein adsorption could be decreased by including PEG in copolymers (K. Furasawa, 1977), with 
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subsequent studies confirming this (Brash & Uniyal, 1979; Whicher & Brash, 1978).  Only a few 
years later, it was shown that PEG surfaces incurred lower platelet adhesion than PVP surfaces (Mori 
et al., 1982).  Merrill made a strong argument that PEG may be one of the least thrombogenic 
materials available (Edward W Merrill & Salzman, 1983), convinced by multiple studies performed 
by his own lab as well as results other labs (E W Merrill et al., 1982; Sa Da Costa, Brier-Russell, 
Salzman, & Merrill, 1981; V Sa da Costa, D Brier-Russell, G Trudel, D.F Waugh, E.W Salzman, 
1980).  
A wave of research into “PEGylation” of previously studied materials as well as PEG-
copolymers emerged based on these findings supporting PEG as a non-thrombogenic material.  Hill-
West et al. found that coating the surface of the artery treated by balloon angioplasty with PEG-
diacrylate  nearly eliminated restenosis normally induced by the procedure (Hill-West, Chowdhury, 
Slepian, & Hubbell, 1994).  In an attempt to prevent adhesions that frequently occur as a result of 
certain surgical procedures, Hubbell developed a PEG-polylactide surgical sealant (Sawhney, Pathak, 
& Hubbell, 1993).  Though results in humans were relatively difficult to assess, these sealants 
performed relatively well in small animals and were later adapted for use in lung (Porte et al., 2001) 
and brain (Preul, Campbell, Bichard, & Spetzler, 2007) surgeries. 
1.3.2 PEG Resistance to Protein Adsorption 
PEG has the unique ability to form a “hydration shell” due to each PEG unit being hydrated 
by three water molecules (indicated by both Raman scattering and NMR analysis) and the resultant 
hydrogen bonding; these shells possibly extending several hundred angstroms from the PEG 
backbone (Horne, Almeida, Day, & Yu, 1971; Kjellander & Florin, 1981; K. J. Liu & Parsons, 1969; 
Maxfield & Shepherd, 1975; Muller & Rasmussen, 1991). PEG is thought to have considerable 
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resistance to non-specific protein adsorption as a result of both this hydration shell and steric 
repulsive forces of the polymer chains (Jeon, Lee, Andrade, & de Gennes, 1991; McPherson, Shim, & 
Park, 1997). The effects of these repulsive forces can be enhanced by increased packing of the 
polymer chains and longer chain lengths. Thus, as the molecular weight and density are increased, the 
resistance of PEG to protein adsorption is amplified (Jeon et al., 1991). Adding to the resistance, 
PEG’s overall neutral charge, in combination with the hydration shell, provides very few binding sites 
for proteins to attach via electrostatic forces (Ostuni, Chapman, Holmlin, Takayama, & Whitesides, 
2001; Whitesides, 1993). In multiple studies,  PEG chains have been reacted to the surfaces of 
proteins and enzymes, preventing immunologic recognition as well as clearance of these 
biomolecules when injected into the blood stream ( a. Abuchowski, McCoy, Palczuk, van Es, & 
Davis, 1977; A. Abuchowski, van Es, Palczuk, & Davis, 1977). Immunologic resistance could be 
accomplished through the covalent attachment of higher molecular weight PEG chains at lower 
densities of coupling. 
Though its resistance to protein adsorption makes PEG desirable for use as a biomaterial, it 
does lack some of the advantageous structural properties possessed by other polymers currently used 
in the manufacturing of implanted devices. Frequently, to combat this deficiency, PEG is used in the 
formation of hydrogels (Nguyen et al., 2013; Roam et al., 2014; Sawhney et al., 1993; Wacker, Scott, 
Kaneda, Alford, & Elbert, 2006; Zisch et al., 2003) or grafted or coated onto the surfaces of other 
materials (Burchenal et al., 2002; Heuberger, Drobek, & Spencer, 2005; Ma, Hyun, Stiller, & 
Chilkoti, 2004; McPherson et al., 1997).  The development of PEG-based materials commonly uses 
PEG derivatives, due to the hydroxyl moiety’s low reactivity. Numerous methods for the highly 
efficient synthesis of PEG derivatives were developed by Harris et al. These methods initially formed 
either a PEGtosylate or PEG-mesylate that could be displaced in subsequent reactions with minimal 
chain cleavage (Harris et al., 1984). Dacron surfaces with PEG-diisocyanate grafted onto them were 
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shown to have significantly decreased platelet adhesion and fibrinogen adsorption (Burchenal et al., 
2002). Generation of surface radicals with UV light allowed for the attachment of PEG to Dacron via 
graft polymerization (Uchida, Uyama, & Ikada, 1994). Cell in-growth matrices have been formed 
using four-arm PEG-VS hydrogels by covalently retaining integrin-binding RGD peptides and 
substrates for matrix metalloproteinases (Zisch et al., 2003).  
1.3.3 Chemical Functionalization of PEG 
The hydroxyl end-groups of PEG can be functionalized with vinyl-sulfones which, 
subsequently, can be utilized for hydrogel formation via crosslinking of PEG molecules, biological 
factor retention, and covalent attachment to surfaces of materials, all under mild physiological 
conditions (Wacker et al., 2006; Zisch et al., 2003).  In the presence of nucleophiles, α,β conjugated 
compounds undergo Michael-type nucleophilic addition reactions.  Vinyl sulfone has been shown to 
participate in such reactions in a pH dependent manner (Masri & Friedman, 1988).  Under neutral 
conditions thiol-containing molecules will readily alkylate PEG-VS, and under slightly basic 
conditions amine-containing molecules will do the same. This allows for conjugation to proteins via 
selective reactivity with either cysteines or lysines. It is, therefore, possible to attach biological 
molecules containing cysteines and/or lysines to PEG-VS containing gels under mild physiological 
conditions, thereby avoiding denaturation or unwanted side-reactions.  Lutolf, et al, successfully used 
this ability to conjugate hydrogels with cell adhesion peptides and to crosslink enzymatically 
degradable peptides into them (M P Lutolf et al., 2003).   
1.3.4 Poly(Ethylene Glycol) Scaffolds 
Tissue engineering scaffolds are able to promote tissue healing and/or regeneration by 
providing structures with specially designed mechanical and biochemical properties necessary for 
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maintaining cell viability and directing cell proliferation and differentiation (Place, George, Williams, 
& Stevens, 2009). The goal of current advancements in scaffolds is to design a biomaterial makeup 
capable of eliciting specific cellular interactions and responses at the molecular level while 
minimizing unfavorable nonspecific biological activity (Hench & Polak, 2002). PEG derivatives and 
copolymers, with their chemical versatility and specificity, have been the focus of many emerging 
strategies to create these scaffolds.   The Hubbell group, who have focused on developing PEG 
hydrogel scaffolds under mild conditions via the vinyl sulfone derivative of PEG,  has achieved in 
situ formation of cell niches of cells migrating and proliferating within a scaffold through the 
fabrication of cell-laden PEG-VS hydrogels crosslinked with MMP-degradeable peptides (M P Lutolf 
et al., 2003). Malda et al, used poly(ethylene glycol)-terephthalate, a completely synthetic PEG 
copolymer, fibers in porous scaffolds for the engineering of articular cartilage to enhance scaffold 
stiffness,  achieving elastic moduli up to 4.33 MPa (Malda et al., 2004, 2005).  
In the quest to achieve an ideal tissue engineering scaffold, scaffolds containing high 
percentages of PEG have been fabricated to minimize nonspecific protein adsorption and cell 
adhesion while maintaining a hydrogel structure desirable for achieving high levels of water content 
and nutrient transfer. Some of these scaffolds have also allowed for the incorporation of biomolecules 
either at the backbone level or in the form of end-group conjugation to impart specific bioactivity 
and/or cell-initiated mechanisms of degradation (Jo et al., 2010; Lih, Yoon Ki Joung, Jin Woo Bae, & 
Ki Dong Park, 2008; Marquardt & Willits, 2011; Miller et al., 2010; Raeber, Lutolf, & Hubbell, 2005; 
Zisch et al., 2003). However, it would be extremely advantageous for these scaffolds to fabricated 
with a rapid, scalable, and modular process (Lampe, Antaris, & Heilshorn, 2013; E. a. Scott et al., 
2010; R. a. Scott, Elbert, & Willits, 2011; Serban & Prestwich, 2008). Porosity at multiple length 
scales to provide niches for embedded cells and routes of vascularization (E. a. Scott et al., 2010; H. 
Wang, Leeuwenburgh, Li, & Jansen, 2012; Wu et al., 2011), adjustable stiffness to mimic the 
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physical characteristics of different types of tissues (Lampe et al., 2013; Serban & Prestwich, 2008), 
and gradients in various properties (Dormer et al., 2010; Roam et al., 2014, 2010; E. a. Scott et al., 
2010; Singh et al., 2008; X. Wang et al., 2009) could be incorporated into scaffolds through modular 
means.  
1.4 Peripheral Nerve Injury and Treatment 
Peripheral nerve injury (PNI) affects up to up 1-3% of all traumatic injuries, approximately 
500,000 Americans each year, with as many as 360,000 upper limb extremity injuries alone (Kelsey 
& Praemer A., 1997; Pfister et al., 2011; Taylor, Braza, Rice, & Dillingham, 2008). PNIs often result 
in chronic or permanent loss of motor function and sensation due to the limited regenerative capacity 
of the peripheral nervous system (PNS), leading to over 8.5 million restricted activity and 5 million 
bed/rest disability days (Kelsey & Praemer A., 1997). A $1.68 billion industry has emerged to combat 
PNS injury and neuropathy, given its high prevalence compared to spinal cord injury, which has led 
to a significant focus on faster regeneration (Brattain, 2012). 
Depending on the type and severity of nerve trauma, surgical intervention may be needed to 
aid in axonal regeneration to distal end organs, such as muscle or skin. Less than 25% of patients with 
PNI’s recover proper motion and less than 3% recover full sensation despite the nearly 200,000 
surgeries performed each year in an attempt to regain lost motor and sensory function, (Archibald, 
Shefner, Krarup, & Madison, 1995; Mackinnon SE & AL Dellon, 1988; Madison, Archibald, & 
Krarup, 1992). Currently, clinical options to bridge nerve gaps include nerve autografts, acellular 
nerve allografts (ANAs), and hollow biomaterials conduits (Szynkaruk, Kemp, Wood, Gordon, & 
Borschel, 2012). The gold standard of these treatments are autografts obtained from the patient, as 
they support the adequate regeneration without eliciting an immune response. However, a better 
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clinical alternative is still needed due to distinct disadvantages such as donor site morbidity, increased 
surgery time, risk, and cost, as well as size and phenotype mismatch (Brenner, Dvali, Hunter, 
Myckatyn, & Mackinnon, 2007; Moradzadeh et al., 2008). ANAs, while similarly providing physical 
guidance to regenerating axons through the underlying basal lamina, induce a limited immune 
response due to the removal of cellular components. Hollow conduits can provide a basic level of 
regenerative support, but due to insufficient growth supporting factors they often fail in large (>1cm) 
nerve gaps (Whitlock et al., 2009). 
1.4.1 Causes of Peripheral Nerve Injury and Obstacles to Repair 
PNIs are most often the result of lacerations, gunshot wounds, stretch or traction, 
compression, drug injection, and surgical injury (Eser, Aktekin, Bodur, & Atan, 2009; Robinson, 
2000). Systemic diseases, such as diabetes, chronic inflammation, kidney disorders, vascular damage, 
repetitive stress, cancer, and toxins also contribute to PNI’s, though to a lesser extent (NINDS, 2014). 
Correct regeneration to the end organ targets (muscle and skin) can be hindered by significant fibrous 
scarring and large gaps between the proximal and distal nerve stumps. Because of this, complete 
recovery rarely occurs and leads to chronic pain, loss of function, and muscle atrophy. Swelling and 
fibrous scar build up are major inhibitors of complete reinnervation and functional recovery (Burnett 
& Zager, 2004; Stroncek & Reichert, 2007).  This scarring around the proximal nerve stump can stop 
regenerating axons in their tracks and can even cause them to swirl if not surgically removed (Burnett 
& Zager, 2004). Surgical intervention is almost always required in such injuries. Any scarring must 
be removed, and the proximal and distal stumps must be reconnected either though direct end to end 
anastomosis or grafting techniques (Quan & Bird, 1999; Siemionow & Sonmez, 2007). In many 
surgical cases, however, direct end-to-end anastomosis (reconnection) is not the optimal treatment 
due to several disadvantages (G Lundborg & Rydevik, 1973; Trumble & Shon, 2000; Wolford & 
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Stevao, 2003). Strategies to bridge axons from the proximal to distal nerve stumps and, thus, 
overcome these difficulties have been undertaken.  
1.5 Methods for PNI Treatment 
1.5.1 Biological Treatments 
Surgeons repairing severely crushed, lacerated or neuromas containing peripheral nerves, in 
order to find tissue suitable for surgical reconnection, may be forced to remove a significant portion 
of the damaged area (Trumble & Shon, 2000).  This removal of damaged tissue that could lead to scar 
formation can leave a considerable gap that could cause unwanted tension if the two stumps were 
simply brought together. This prevents standard end-to-end coaptation of the nerve stumps from 
being a viable option for small injuries. Nerve “bridges” must be employed in these cases to join the 
proximal and distal stumps while avoiding any negative effects of tension. Autologous nerve grafts, 
or autografts, have proven to be the gold standard for these bridges in clinical situations.  For the 
autograft, a minor nerve of the patient, such as the medial antebrachial cutaneous nerve (MABCN), 
the lateral antebrachial cutaneous nerve, or more typically, the sensory saphenous or sural nerves in 
the leg, is harvested and sutured to the proximal and distal stumps (Schonauer, Marlino, 
Avvedimento, & Molea, 2012). The loss of small, minor nerves like these will not impair motor 
function. Because they are harvested from the patient, immunosuppressants, used in the case of grafts 
taken from cadavers, are not necessary. Grafts such as these generally result in the best regeneration 
possible.  Though autografts have shown great aptitude to promote regeneration, there are a number 
of negative aspects to them as well. As previously stated, the loss of a minor, sensory nerve will not 
generally impair motor function. However, morbidity at the donor site will cause loss of sensation 
and, potentially, chronic pain. Surgery time, cost, and risk of infection are all increase with the 
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addition of a second surgical site (Pfister et al., 2011; Schonauer et al., 2012). Lastly, in large 
diameter motor nerves, grafts of matching phenotype are more effective in promoting regeneration 
than small sensory nerves (Brenner et al., 2006; Moradzadeh et al., 2008). This is due to not only the 
size mismatch, but also sensory vs. motor phenotype mismatch. Research has been looking at 
alternative solutions for grafting nerve defects in order to overcome these obstacles. 
Chiu et al found that the use of autologous vein grafts can lead to positive sensory recovery in 
1982.  Autologous vein grafts address two of the main drawbacks of autografts in their accessibility 
and lack of donor-site morbidity. These vein grafts can be harvested and used to act as conduits 
between the nerve stumps. The study, using a rat sciatic nerve model, reported the use of 1 cm vein 
grafts resulting in ordered nerve regeneration, healing of plantar ulcers, and nearly normal muscle 
fibers of the gastrocnemius muscle (Chiu, Janecka, Krizek, Wolff, & Lovelace, 1982). Many 
following studies sought to translate the technique to human regenerative success. Walton et al., using 
1-3 cm vein grafts in patients with acute digital nerve repair, reported return of sensation in 50% of 
cases (Walton, Brown, Matory, Borah, & Dolph, 1989). However, use of these vein grafts tended to 
delay nerve repair, resulting in poor regeneration and functional recovery. A subsequent Chiu et al. 
study, along with these previous results, did show that autologous nerve grafts result in favorable 
sensory recovery when limited to small defects (3 cm) in nonessential sensory nerves that affect a 
limited end organ target area (Chiu & Strauch, 1990).  Various factors such as vessel wall collapse, 
physical structure, and neurotrophic support could explain the lack in success past 3 cm gaps (Demir 
et al., 2014; Schonauer et al., 2012; Strauch et al., 1996). Another issue is their lack of neurotrophic 
factors which promote regeneration and functional recovery. Multiple attempts have been made to 
rectify this issue by treating grafts with growth factors, such as NGF, seeding olfactory ensheathing 
cells, and by placing minced nerve tissue or muscle within the graft (Lokanathan et al., 2014; Pu et 
al., 1999; Sahin et al., 2014). Thus, autologous vein grafts, while promising, lack many of the 
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necessary physical characteristics needed to enhance functional regeneration in large diameter, long 
gap nerve defects. 
The acellular nerve allograft (ANA) is one of the most promising clinical alternatives to 
autografts. Nerve allografting provides a nearly unlimited source of tissue, as they are harvested from 
cadaveric donor nerves, and circumvents issues of donor site morbidity, associated risks of multiple 
surgeries, etc. found in autograft.  The major dowside of allografts, however, is their need for proper 
immunosuppression of the host patient to prevent rapid rejection (Siemionow & Sonmez, 2007). 
1.5.2 Synthetic Nerve Guidance Conduits 
Research into commercially viable materials for nerve grafts in hopes of replacing autografts, 
with their numerous downsides and limited availability, began in the 1980s. Because clinicians 
seeking to bridge the proximal and distal nerve stumps were principally seeking a conduit to that 
could be easily handled and sterilized, the first conduits were simple hollow tubes made of 
nonresorbable silicone (G Lundborg, Gelberman, Longo, Powell, & Varon, 1982). These conduits led 
to compression of the nerve due to the lack of degradation, which impeded regeneration and required 
a second surgery to remove (G Lundborg & Dahlin, 1992; G Lundborg et al., 1982; Göran Lundborg, 
2000). It was quickly determined that certain requirements would need to be met if nerve guidance 
conduits (NGC) were to be a viable clinical solution for promoting regeneration. The ideal NGC 
would need to be biocompatible, biodegradable, flexible, have physical and mechanical properties 
that support nerve regeneration, nutrient permissible, and growth permissive (Kehoe, Zhang, & Boyd, 
2012). This led to the development of conduits made of collagen, poly (lactic-co-glycolic acid) 
(PLGA), and poly (glycolic acid) (PGA) to meet these basic requirements (Daly et al., 2012; Nectow, 
Marra, & Kaplan, 2012; S. Wang & Cai, 2010).  Collagen conduits are bioresorbable, made of a 
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native ECM protein that supports axon growth, and biocompatible on the large scale, many of the 
properties considered ideal for regeneration. Conduits consisting of a hollow tube with a porous wall 
made from type I collagen are sold from Neurogen® and have been shown to be capable of 
encouraging regeneration across small nerve defects in animal models (Kemp, Syed, Walsh, 
Zochodne, & Midha, 2009). Unfortunately, of using natural polymers, such as collagen, to form 
NGCs incurs two shortcomings, batch-to-batch variability in collagen production and poor 
mechanical properties to support regenerating axon cables (Ciardelli & Chiono, 2006; Schmidt & 
Leach, 2003). 
Due to these drawbacks, companies began investigating NGCs made from synthetic polymers, 
which elicit a lower immune and inflammatory response and have highly tunable mechanical and 
degradation properties. Bioresorbable conduits made from PGA (Neurotube®) and PLGA have 
shown promise in promoting axonal regeneration (S. Wang & Cai, 2010). These conduits, which are 
easy off-the-shelf products that can be sterilized and handled without difficulty, have shorter surgery 
time than autografts and minimize risk of infection, distinct advantages in a clinical setting.  These 
conduits continue to fail clinically in large diameter, large nerve defects, despite all these positive 
attributes.  Part of this discrepancy between small and large diameter nerves is due to the volume 
within the conduit increasing by the power of 2 as the diameter of the nerve increases (A. M. Moore 
et al., 2009; Pfister et al., 2011). Accordingly, to properly compare results of regenerating tissue 
between small and large diameter nerves, the gap length must be decreased by that same factor to 
keep the volumes equal. This volumetric effect, especially the effect on concentrations of biological 
factors and mechanical properties, must be taken into account if large defects are to be bridged by 
conduits, or even biological grafts, such as ANAs or vein grafts.  Conduits must be designed in a way 
that will support axonal regeneration physically, biochemically, and functionally. The following 
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sections will cover current strategies to engineer scaffolds with these stipulations to promote 
peripheral nerve regeneration. 
1.5.3 Engineering Topographical Cues within Conduits 
Most commercially available NGCs are hollow tubes or nerve wraps that lack native nerve 
architecture, and many groups are working to remedy this by developing materials that contained 
within conduits could provide guidance to extending nerves after injury. Highly aligned, porous 
biomaterial scaffolds have been developed by several groups using both natural (Cullen et al., 2012; 
Davidenko et al., 2012; Pawar et al., 2011; Suri et al., 2011) and synthetic materials (Fan et al., 2011; 
L. He et al., 2009; Yang et al., 2009) seeking to guide regenerating axons by providing longitudinally 
aligned substrates.  Conduit porosity might also play an important role along with intraluminal 
porosity and topography. Oh et al. observed increased longitudinal regeneration in conduits with 
nanopores, while conduits with micropores incurred regeneration into the pores suggesting that 
increased porosity may decrease axonal regeneration toward the distal nerve segment (Oh et al., 
2012).  Daly et al. showed the use of ultrastructured, grooved collagen fibers within aligned conduits 
aid regenerating axons in vivo.  Electrospinning is one of the most popular methods of creating 
aligned biomaterial substrates.  Electrospun scaffolds have been shown to promote cell migration and 
guide neurite extension from DRGs in vitro (Mukhatyar et al., 2011). Electrospun scaffolds are often 
fabricated from synthetic materials, such as PCL (Greiner & Wendorff, 2007; Kijeńska, Prabhakaran, 
Swieszkowski, Kurzydlowski, & Ramakrishna, 2012; Lee et al., 2012; Ng et al., 2001; Xie, 
MacEwan, Li, Sakiyama-Elbert, & Xia, 2009; Xie, Willerth, et al., 2009), poly-acrylonitrile (PAN) 
(Kim, Haftel, Kumar, & Bellamkonda, 2008), and poly-L-lactic acid (PLLA) (Kijeńska et al., 2012), 
and natural materials, such as silk, collagen, and blends of silk and PLLA (Moroder et al., 2011; S. Y. 
Park et al., 2012). Aligned electrospun fibers, compared to randomly aligned electrospun fiber mats, 
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promoted significantly enhanced axon regeneration in a sciatic nerve injury model, yielding increased 
nerve fiber number, electrical activity, and motor reinnervation (Kim et al., 2008; Moroder et al., 
2011; Neal et al., 2012; Zhu et al., 2011).  
Artificial Bands of Büngner, structures created by Schwann cells, were created by Ribeiro-
Resende et al. through aligned collagen and poly--caprolactone (PCL) filament constructs.  These 
aligned microfilaments could be seeded with Schwann cells and, thereafter, promote enhanced, 
oriented outgrowth of dorsal root ganglia (DRG) neurites in vitro (Ribeiro-Resende, Koenig, 
Nichterwitz, Oberhoffner, & Schlosshauer, 2009). This study also achieved increased Schwann cell 
orientation, providing better axonal guidance in turn, by using combination of topographical cues, as 
well as what they termed “polarizing” differentiation factors, nerve growth factor (NGF), neuregulin-
1, and transforming growth factor-β (TGF-β). The Schwann cell imprinted molds have been used to 
mimic the native Bands of Büngner architecture by the Hoffman-Kim group (Bruder, Lee, & 
Hoffman-Kim, 2007).  Created from aligned Schwann cell substrates, these cell topographical molds 
were capable of promoting highly aligned neurite outgrowth from DRG neurons in vitro. This group 
then adapted this Schwann cell-mimicked topography into conduits capable of influencing DRG 
neurite extension, as well as cell migration patterns (Richardson, Rementer, Bruder, & Hoffman-Kim, 
2011).  These studies show the importance in designing scaffolds that provide structure similar to that 
of native nerve architecture, as well as topological guidance for regenerating axons to the distal target 
of innervation. 
1.5.4 Engineering Chemical Cues within Conduits 
In addition to topographical cues, incorporating important growth factors and adhesion cues, 
such as neurotrophic factors (NF) and extracellular matrix (ECM) proteins will also critical to 
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engineering NGC’s, if not more so.  The role of laminin in nerve regeneration has been well studied, 
due to its mediation of cell survival, axon extension and cell adhesion through specific peptide 
sequences, IKVAV and YIGSR, as well as important integrin signaling (Jurga et al., 2011; Marquardt 
& Willits, 2011; Neal et al., 2012; Swindle-Reilly et al., 2012; Zustiak, Durbal, & Leach, 2010). Cao 
et al. developed a number of laminin-based systems. Laminin was covalently attached to linear 
ordered collagen scaffolds to promote axonal regeneration.  Cilliary neurotrophic factor (CNTF) and 
brain-derived neurotrophic factor (BDNF) were delivered using laminin via laminin-binding domains 
(LBD) within the proteins. While laminin alone improved myelinated axon number in vivo, additional 
improvement in axon regeneration and conduction velocity of the regenerating sciatic nerve through 
the controlled delivery of CNTF through the LBD (J. Cao et al., 2011). The LBD was also employed 
for controlled delivery of BDNF and CNTF, which showed improved compound muscle action 
potential (CMAP) activity of rat facial nerves (J. Cao et al., 2013). Incorporation of biochemical 
factors including laminin, CNTF, BDNF, and many others (tested and untested) indicate that these 
cues can further enhance functional outcomes in addition to structural effects from the collagen 
scaffold. 
ECM proteins found in the native nerve architecture have also been successfully incorporated 
into biomaterial scaffolds to enhance neurite outgrowth in vitro and in vivo. Fibronectin, an ECM 
protein that is important for cell migration and adhesion via integrin binding to the RGD peptide, has 
been shown to promote neurite extension in vitro when combined with various polymer scaffolds 
such as aligned electrospun PAN-methacrylate, collagen, and PEG (Mukhatyar et al., 2011; Zhou, 
Blewitt, Hobgood, & Willits, 2012).  Synthetic polymers have also been modified by collagen in 
order to promote enhanced neurite outgrowth and axon regeneration (Lee et al., 2012; R. Scott, 
Marquardt, & Willits, 2010). Lampe, et al. created elastin-like protein hydrogels, providing RGD 
binding sites and mimicking native nerve mechanical properties, which  increased neurite extension 
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from DRG’s significantly in vitro (Lampe et al., 2013). Biomaterial scaffolds with optimal adhesion 
properties for regenerating axons could be fabricated using these tunable hydrogels. 
Scaffolds from both synthetic and natural polymers have been functionalized to deliver NFs 
and ECM proteins through various chemical crosslinking methods. Affinity peptides have proven 
useful for the controlled delivery of NF’s in a number of studies.  Shepard, et al. used to functionalize 
PEG hydrogels in order to locally deliver viral vector constructs for NGF, as well as NGF, promoting 
increased neurite outgrowth from DRGs in vitro (Shepard et al., 2011). Wood, et al. created NGC’s 
containing fibrin matrices with an affinity peptide system for delivery of NGF and GDNF , which 
promoted enhanced motor regeneration, target reinnervation and functional recovery (A. M. Moore et 
al., 2010; Wood, Borschel, & Sakiyama-Elbert, 2009; Wood et al., 2010).  Heparin, which reversibly 
binds many NF’s, has also been added to many systems for controlled delivery (Joung, Bae, & Park, 
2008; Nie et al., 2007; Oh et al., 2011; Roam et al., 2014; Sakiyama-Elbert & Hubbell, 2000; Tae et 
al., 2006). NFs and ECM proteins can be delivered in a controlled manner from non-reversible 
chemical conjugation methods, as well as these affinity-based systems, and may provide an ideal 
solution for in vivo regeneration (Cho, Choi, Jeong, & Yoo, 2010; Hsieh et al., 2011; Roam et al., 
2010; R. a. Scott et al., 2011; Vulic & Shoichet, 2012; Xu, Yan, & Li, 2011). 
1.6 Glial-Cell Line Derived Neurotrophic Factor 
Originally isolated from the supernatant of a rat glioma cell-line, GDNF is a part of the 
cysteine-knot family of the transforming growth factor- (TGF-) superfamily that has been found to be 
effective in increasing dopaminergic neuron survival (Airaksinen & Saarma, 2002; Saarma, 2000).  
GDNF has since been utilized in treatment strategies for diseases affecting dopaminergic and motor 
neuron populations after it was demonstrated that GDNF to also promotes motor neuron survival 
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(Airaksinen & Saarma, 2002; Arce et al., 1998; Chu et al., 2012; Herrán et al., 2013). GDNF binds to 
a GDNF-family receptor (GFR), as do most factors in the GDNF-family of ligands, particularly a co-
receptor for Ret, receptor tyrosine kinase called GFR1 (Hase et al., 2005). GFR1 is anchored to the 
plasma membrane using lipid rafts, which has been shown to be an important component in GDNF 
signaling (Hase et al., 2005; Iwase, Jung, Bae, Zhang, & Soliven, 2005). Ret is actively recruited to 
this lipid raft following the binding of GDNF to the glycosylphosphatidylinositol (GPI)-anchored 
GFR1, which allows for autophosphorylation (Airaksinen & Saarma, 2002). Ret, a proto-oncongene 
found in neurons, activates its intracellular tyrosine kinase domain upon binding, contributing to 
downstream signaling via the activation of Src-family kinases. Dopaminergic, motor, 
parasympathetic, sympathetic, and sensory neuron survival are all aided by this signaling pathway 
(Bennett et al., 1998). Upregulation of GDNF and its receptors may be induced initially by PNI 
(Hoke, Bell, & Zochodne, 1998; A. Höke, Cheng, & Zochodne, 2000).  However, decreased levels of 
GDNF signaling, which may cause failures in functional regeneration and result in neuropathic pain, 
has been displayed subsequently in cases of chronic denervation of nerves ( a Höke, Gordon, 
Zochodne, & Sulaiman, 2002; Nagano et al., 2003). Thus, GDNF has been studied extensively for its 
ability to enhance both motor and sensory neuron regeneration in PNI (A. Höke, 2006). Chen, et al. 
found that GDNF, delivered via a simple local intramuscular injection, significantly improved motor 
neuron survival, as well as elongation of both sensory and motor nerves (Chen, Chu, Chen, & Li, 
2010). Painful neuropathies have been treated with intrathecal delivery and even topical applications 
of GDNF with some success (Boucher et al., 2000; Hedstrom, Murtie, Albers, Calcutt, & Corfas, 
2014; A. Höke, 2014).  A number of methods used to locally deliver GDNF to sciatic nerves have 
resulted in significant improvement in axonal regeneration (Fine, Decosterd, Papaloïzos, Zurn, & 
Aebischer, 2002; Wood, Moore, et al., 2009). Most significantly, however, GDNF delivery, in 
addition to just increasing nerve fiber number, has shown the ability to promote proper motor 
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reinnervation leading to enhancement in functional motor recovery (Lin et al., 2011; A. M. Moore et 
al., 2010; Wood, Moore, et al., 2009). 
1.6.1 Strategies for Controlled Delivery of GDNF  
Because GDNF has been shown so clearly to positively affect nerve regeneration, the issue 
becomes how to effectively and precisely deliver it in a controlled manner. Drug clearance occurs 
rapidly in the body, so the ability to control or sustain the delivery of a compound, in this case GDNF, 
should dramatically improve its effectiveness (Panyam & Labhasetwar, 2003). The simplest mode of 
delivery is systemic injection. However, the targeted areas rarely get a sufficiently high and sustained 
enough dosage to have the desired effect. A wide range of systems, including cell and gene-based 
delivery, affinity-based systems,  and diffusion and degradation-based methods, have been conceived 
and tested, with varying degrees of success, to treat PNI with local delivery of GDNF (Magill et al., 
2010; Ramburrun et al., 2014).  
GDNF, as well as a variety of other growth factors, has been targeted for gene delivery and 
transfer, and PNI therapies using this have shown promise (De Winter et al., 2013; Mason, 
Tannemaat, Malessy, & Verhaagen, 2011). In chronically damaged sciatic nerves, intramuscular 
injections of GDNF adenovirus lead to improved myelination and behavioral outcomes (J.-Y. Shi et 
al., 2011). This method was also employed in treating diabetic neuropathy resulting in improving 
neurological functions due to increased sensory neuropeptide and the GDNF signaling cascade levels 
for 21-35 days (G.-S. Liu et al., 2009; J.-Y. Shi et al., 2011).  Injection of GDNF lentiviral vectors 
directly into injured peripheral nerves increased local GDNF production and improved sensory axon 
recovery and pain levels, but also led to at the site of GDNF production, termed the “candy-store 
effect” (Eggers et al., 2008; Tannemaat et al., 2008). Cell-based delivery of GDNF using retroviral 
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(Q. Li, Ping, Jiang, & Liu, 2006), lentiviral (Eggers et al., 2013; Hoyng et al., 2014; Santosa et al., 
2013; Shakhbazau et al., 2013; Y. Shi, Zhou, Tian, & Wang, 2009), and non-viral transfection (Kraus 
et al., 2010) techniques have been used in multiple in vitro and in vivo studies, yielding some positive 
results, though many incurred problems with cell death and, once again, motor neuron entrapment at 
the delivery site.  
Multiple strategies using diffusion-based local delivery of growth factors, including GDNF, 
has been developed by many groups. The simple systems soak biomaterial sponges, bulk gels, and 
electrospun scaffolds in GDNF, relying on passive diffusion of the growth factor through the material 
to reach regenerating axons (Catrina, Gander, & Madduri, 2013; Chew, Mi, Hoke, & Leong, 2007; 
Fine et al., 2002; Madduri, di Summa, Papaloïzos, Kalbermatten, & Gander, 2010; Madduri, 
Feldman, Tervoort, Papaloïzos, & Gander, 2010). Release from these systems is generally not 
sustained for long periods of time, and the burst release profile usually generated by this passive 
diffusion is normally cleared away quickly. Degradable, hollow microspheres containing GDNF have  
been explored a few groups (Aubert-Pouëssel et al., 2004; Clavreul et al., 2006; Wood et al., 2012; 
Xiao & Zhang, 2010). Degradable microspheres allow for a 2-phase release system in which GDNF 
can diffuse slowly out of the microspheres, followed by a larger release as the microspheres degrade. 
PLGA microspheres loaded with GDNF and contained within a NGC, as discussed previously, has 
led to significant improvements in axonal regeneration and functional motor output, even after 
delayed repair (Borschel et al., 2012; Wood et al., 2012, 2013). The release of GDNF from PLGA 
microspheres has been further slowed by the addition of another diffusive barrier in the form of a 
PCL conduit (Kokai, Bourbeau, Weber, McAtee, & Marra, 2011; Kokai, Ghaznavi, & Marra, 2010). 
Materials such as silk, chitosan, and PCL have also been used to effectively deliver GDNF in a 
sustained manner (X. Wang et al., 2007; Wen et al., 2011; Wu et al., 2011). 
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The use of affinity-based delivery systems (ABDS), which rely on electrostatic interactions 
between growth factors and other molecules, such as glycosaminoglycans (GAGs), to slow their 
release by sequestration, provides a good alternative to the uncontrolled passive diffusion or release 
from materials. As previously mentioned, the heparin-based delivery system (HBDS) is an affinity-
based system that has been well characterized and used in a multitude of tissue regeneration studies 
(Sakiyama-Elbert & Hubbell, 2000; Wood et al., 2010). Heparin, which is the most negatively 
charged, highly sulfated GAG and one of the negatively charge biological molecules, has been used 
intensively for anti-coagulation applications for decades (Howell & Holt, 1918; Salek-Ardakani, 
Arrand, Shaw, & Mackett, 2000). Many growth factors, which have an affinity for heparin, can be 
immobilized by its inclusion within a scaffold. Sakiyama-Elbert, et al. non-covalently attached 
heparin to fibrin through a bi-domain peptide sequence in order to sequester growth factors within 
fibrin scaffolds (Sakiyama, Schense, & Hubbell, 1999; Sakiyama-Elbert & Hubbell, 2000). Wood et 
al. showed, in vitro, this method created controlled release of GDNF for up to two weeks and 
increased neurite extension (Wood, Borschel, et al., 2009) and later showed, in vivo, resulted in 
increased axon regeneration, fiber width, motor neuron survival and muscle reinnnervation, and, most 
importantly, functional motor recovery for a 13-mm gap repaired with a silicone conduit (A. M. 
Moore et al., 2010; Wood et al., 2010; Wood, Moore, et al., 2009).  
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Chapter 2* 
The formation of protein concentration 
gradients mediated by density differences of 
poly(ethylene glycol) microspheres  
 
2.1 Abstract 
 A critical element in the formation of scaffolds for tissue engineering is the introduction of 
concentration gradients of bioactive molecules. We explored the use of poly(ethylene glycol) (PEG) 
microspheres fabricated via a thermally induced phase separation to facilitate the creation of gradients 
in scaffolds. PEG microspheres were produced with different densities (buoyancies) and centrifuged 
to develop microsphere gradients. We previously found that the time to gelation following phase 
separation controlled the size of microspheres in the de-swollen state, while crosslink density affected 
swelling following buffer exchange into PBS. The principle factors used here to control microsphere 
densities were the temperature at which the PEG solutions were reacted following phase separation in 
aqueous sodium sulfate solutions and the length of the incubation period above the ‘cloud point’. 
Using different temperatures and incubation times, microspheres were formed that self-assembled 
into gradients upon centrifugation. The gradients were produced with sharp interfaces or gradual 
transitions, with up to 5 tiers of different microsphere types. For proof-of-concept, concentration 
gradients of covalently immobilized proteins were also assembled. PEG microspheres containing 
*
 Chapter 2 has been adapted from the following manuscript:  
J. Roam, H. Xu, P. Nguyen, D. Elbert. The formation of protein concentration gradients mediated 
by density differences of poly(ethylene glycol) microspheres. Biomaterials, 31 (2010), pp. 8642–
8650 
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heparin were also fabricated. PEG-heparin microspheres were incubated with fluorescently labeled 
protamine and used to form gradient scaffolds. The ability to form gradients in microspheres may 
prove to be useful to achieve better control over the kinetics of protein release from scaffolds or to 
generate gradients of immobilized growth factors. 
 
2.2 Introduction 
 Concentration gradients of signaling molecules are important in embryogenesis, wound 
healing, immunity, angiogenesis, and nerve cell signaling (X. Cao & Shoichet, 2001; DeLong et al., 
2005; Fisher et al., 1989; Kapur & Shoichet, 2004; Knapp et al., 1999; K. Moore et al., 2006; Parent 
& Devreotes, 1999; Rosoff et al., 2004; Singh et al., 2008; H. Song  & Poo , 2001; H. J. Song et al., 
1997; X. Wang et al., 2009). Therefore, introducing gradients of bioactive signals into scaffolds 
according to some spatial blueprint may be crucial to the engineering of tissues or organs. In 
particular, chemotaxis, the preferential movement of cells up a concentration gradient of signaling 
molecules, is known to be dependent upon the steepness of a concentration gradient as opposed to the 
average concentration of the molecule (Knapp et al., 1999; K. Moore et al., 2006; Parent & 
Devreotes, 1999). This may have particular importance in the development of scaffolds for nerve 
regeneration. Shoichet et al., have demonstrated that concentration gradients of nerve growth factor 
immobilized on a scaffold can be used to enhance the directionality of extending dendrites (Kapur & 
Shoichet, 2004; K. Moore et al., 2006). Bellamkonda et al., showed that gradients of laminin-1 could 
also turn growing dorsal root ganglia towards the increasing concentration and gradients of laminin-1 
and nerve growth factor could promote regeneration of the sciatic nerve in rats (Dodla & 
Bellamkonda, 2008, 2006). 
 
29 
 
Scaffolds formed from hydrogels made of synthetic polymers show significant promise in 
regenerative medicine (Drury & Mooney, 2003; E. a. Scott et al., 2010; Tessmar & Göpferich, 2007). 
Biological functions, such as cell adhesion or cell-initiated degradability, may be incorporated within 
these hydrogels using functional peptides or proteins (Almany & Seliktar, 2005; DeLong et al., 2005; 
M P Lutolf & Hubbell, 2005; E. a. Scott et al., 2010; Zhang, Wang, Wang, Zhang, & Suggs, 2006). 
However, bulk hydrogel scaffolds are typically homogenous structures without macroporosity or 
spatial organization, much different than native tissue. Modular strategies to produce heterogeneous 
scaffolds from hydrogel microparticles show promise in addressing these limitations 
(Khademhosseini & Langer, 2007; Rivest et al., 2007). 
 
A number of systems have been used to produce gradients in scaffolds, including pulsatile 
application of picoliters of growth factor solutions, diffusion of molecules into a gel, and gradient 
makers in which polymerizing solutions exit two different chambers in varying ratios (X. Cao & 
Shoichet, 2001; Kapur & Shoichet, 2004; Knapp et al., 1999; H. J. Song et al., 1997). However, these 
methods have distinct disadvantages, such as scaling issues and difficulty in pumping polymerizing 
solutions. Assembling different types of microparticles in a modular manner may provide the 
versatility necessary to engineer the properties of bioactive scaffolds, including formation of gradients 
(Du, Lo, Ali, & Khademhosseini, 2008; Rivest et al., 2007; E. a. Scott et al., 2010; Serban & 
Prestwich, 2008; Yeh et al., 2006). Mechanical microparticle production techniques (e.g. 
micromolding, microfluidics, 3D printing, etc.), which are most common, may have scalability issues, 
as even small scaffolds can require billions of microparticles to form (Boland, Xu, Damon, & Cui, 
2006; Liu Tsang & Bhatia, 2004; E. a. Scott et al., 2010; Um, Lee, Pyo, & Park, 2008; Yeh et al., 
2006). Previously, we have fabricated PEG hydrogel microspheres in solution via a thermally induced 
phase separation (E. a. Scott et al., 2010). The microspheres were produced by reacting multiarm-
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PEG derivatives in the presence of kosmotropic salts that induced a phase separation upon incubation 
at 37 °C or above. The method can be performed rapidly and at large scales. Different functionalities, 
such as cell adhesion, degradability, and drug delivery, have already been imparted to these 
microspheres as well (E. a. Scott et al., 2010). 
 
The current study explored how to engineer gradients into scaffolds made from these PEG 
microspheres. We have found that varying the temperature of the phase separation and the amount of 
time the PEG is allowed to react above the cloud point allows us to control both the size and the 
density (buoyancy) of the microspheres. The size of microspheres in their de-swollen state is 
controlled primarily by the time to reach the gel point, while the swelling following buffer exchange 
into PBS is determined by crosslink density(Nichols et al., 2009). The swelling of the microsphere 
should greatly affect the density of the microspheres by changing the ratio of solvent to polymer. By 
incubating batches of microspheres for different amounts of time, a range of densities can be 
produced. The formation of scaffolds from the microspheres is enhanced by centrifugation, exploiting 
small density differences to introduce gradients while simultaneously crosslinking the microspheres 
together to form a scaffold. Proteins can be covalently bound to the microspheres or electrostatically 
attached using heparin in varying concentrations to form concentration gradients of those proteins. 
The methods described herein may allow for the development of gradient-containing scaffolds for a 
variety of tissue engineering and drug delivery applications. 
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2.3 Materials and Methods 
Unless otherwise noted, all reagents were purchased from Sigma–Aldrich. 
 
2.3.1 PEG synthesis and labeling 
Eight-arm PEG-OH (PEG8-OH; mol. Wt. 10,000; Shearwater Polymers, Huntsville, AL) was 
used to synthesize PEG8-vinylsulfone (PEG8-VS) and PEG8-amine as previously described (Wacker 
et al., 2006). PEG macromonomers were dissolved separately at 200 mg/mL in Dulbecco’s phosphate 
buffered saline (PBS; 8 mm sodium phosphate, 2 mm potassium phosphate, 140 mm sodium chloride, 
10 mm potassium chloride, pH 7.4) and sterile filtered with 0.22 μm syringe filters (Millipore). 
Dylight-488 NHS-ester (Pierce), Dylight-633 NHS-Ester (Pierce), and Dylight-549 Maleimide 
(Pierce) were dissolved in dimethyl formamide at 10 mg/mL and added to the PEG8-amine solutions 
at 1600:1, 20:1, or 200:1 mol:mol ratios, respectively, and incubated at 25 °C overnight protected 
from light. 
 
2.3.2 Microsphere formation 
Labeled or unlabeled PEG8-amine solutions were combined with PEG8-VS solutions at a 1:2 
ratio. If the solutions were to be used for microsphere formation at 37 °C, the solutions were pre-
reacted at 37°C for 5–6 h until a mean dPCS = 100 nm was observed by dynamic light scattering (E. 
a. Scott et al., 2010). The PEG solutions (pre-reacted or otherwise) were diluted to 20 mg/mL PEG 
with PBS and 1.5 m sodium sulfate (in PBS) to a final sodium sulfate concentration of 0.6 m. The 
PEG8-VS/PEG8-amine solutions were then incubated above the cloud point at 37°C, 70°C, or 95°C 
for various times (Fig 2.1). Suspensions of microspheres were subsequently buffer exchanged into 
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PBS 2× to remove the sodium sulfate by: (1) diluting the microsphere solution 3:1 with PBS and 
titurating, (2) centrifuging at 14,100 g for 2 min, (3) removing the supernatant. 
 
2.3.3 Gradient formation 
The glass walls of Pasteur pipettes were passivated with PLL(375)-g[7]-PEG(5) (D. L. Elbert 
& Hubbell, 1998; Kenausis et al., 2000). The pipettes were filled with a 20 mg/mL PLL-g-PEG 
solution, incubated for 30 s, and washed with DI water. After sufficient drying time, the tips of the 
pipettes were sealed with silicone aquarium sealant (DAP Inc., Baltimore, MD). To form scaffolds, 
the microspheres were resuspended in 10% Fetal Bovine Serum in DMEM (Invitrogen) after the final 
PBS wash and combined with other labeled microsphere solutions in the Pasteur pipette. The pipette 
was placed in a 15 mL conical vial and centrifuged at 1000 g for 10 min and then incubated overnight 
at 37 °C before viewing (Fig 2.2). 
 
2.3.4 Confocal microscopy 
Fluorescence microscopy was performed with a Nikon Eclipse C1/80i confocal microscope. 
Microsphere gradients were imaged while still in the Pasteur pipettes with a 10× objective (0.30 DIC 
L WD 7.4). Multiple images were taken along the length of the pipette and processed using EZ-C1 
3.70 FreeViewer software (Nikon Instruments Inc.) and then combined.   
 
Figure 2.1. Microsphere Formation 
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2.3.5 GDNF labeling 
Recombinant human glial cell line-derived neurotrophic factor (100 μg/mL, GDNF, R&D 
Systems, Minneapolis, MN) was reconstituted in PBS. Dylight-488 was added to the solution for a 
final concentration of 50 μg/mL and incubated overnight at room temperature. Cysteine (200 μg/mL) 
was added and incubated overnight as well. Bovine serum albumin (0.1%; BSA) was then added to 
the solution to reduce adsorption to the vials. SDS-PAGE showed that while BSA did receive a small 
amount of labeling, the much smaller quantity of GDNF was labeled to a much greater extent (Note: 
 
Figure 2.2. Gradient formation. (a) Microspheres with the same chemical structure but with different 
densities were produced from PEG precursors labeled with different fluorescent dyes.  The microspheres were 
suspended in 10% serum and added to a PLL-g-PEG treated Pasteur pipette. (b) The microspheres were 
initially well mixed. (c) Upon centrifugation, the microspheres separated themselves based on their relative 
densities. 
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For the covalent attachment of GDNF at 37 °C, cysteine was not added, and the BSA was revealed by 
SDS-PAGE to have become significantly labeled.). 
 
2.3.6 Protein attachment to microspheres 
The labeled GDNF/BSA solution was diluted by half in PBS and added in place of the PBS 
along with the sodium sulfate solution and unlabeled PEG solutions (pre-reacted or otherwise). The 
combined solution was then incubated and washed as before to form microspheres. 
 
2.3.7 Heparin attachment 
A solution of 500 mm N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC), 200 mm N-Hydroxy-succinimide (NHS), and 50 mg/mL heparin sodium salt (mol. wt. 
∼18,000) in MES buffer (10 mm, pH 6.0) was incubated at room temperature for 30 min. The 
 
Figure 2.3. Heparin Attachment 
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activated heparin solution was then added to a 200 mg/mL solution of PEG8-amine at a 20:1 PEG8-
amine to heparin mol:mol ratio and incubated at room temperature for another 30 min before 
refrigeration. Microspheres were formed as before using the heparin-conjugated PEG8-amine along 
with PEG8-VS in a 1:2 ratio (Fig. 2.3). 
 
2.3.8 Protamine labeling 
Protamine sulfate salt from salmon (10 mg/mL, Grade X) was dissolved in 50 mm sodium 
borate buffer (pH 8.5). Dylight-488 was added to the solution for a final concentration of 50 μg/mL 
and incubated overnight at room temperature. As before, a PD-10 Sephadex G-25M column (Supelco, 
Bellefonte, PA) was used to remove any unbound Dylight-488. The column was washed with ∼20 
mL PBS before adding the labeled protamine solution. After the sample entered the column, 2.4 mL 
of PBS was added and allowed to flow through. The labeled protamine was eluted with 20 mL PBS, 
and the flow through was collected in 0.5–0.75 mL fractions. The fluorescence of each fraction was 
measured with a fluorometer and the protein-containing fraction with peak fluorescence was retained. 
The final concentration of labeled protamine in the peak fraction was ∼1 mg/mL. 
 
2.3.9 Protamine attachment to heparin microspheres 
After the PBS washes, the microspheres were spun down, and the supernatant was removed. 
The labeled protamine solution was diluted to 25 μg/mL in PBS and added to the dehydrated 
microspheres. The microspheres were incubated with the protamine solution at room temperature 
overnight. 
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2.4 Results 
2.4.1 Formation of Microsphere Gradients 
Density measurements of microspheres with Histopaque-1077 and Histopaque-1119 
demonstrated that microspheres under all formation conditions migrated to the interface of the two 
solutions. This showed that all the microspheres had specific gravities between 1.077 and 1.119. Thus 
density differences across the spectrum of formation conditions were quite subtle. To determine if the 
density differences between microspheres were sufficient to generate microsphere gradients, PEG8-
amine was fluorescently labeled using one of three different dyes and used to form microspheres with 
different densities. In all of the experiments presented here, microspheres in any one scaffold were 
formed at the same temperature (37, 70 or 95 °C) but incubated above the cloud point for different 
lengths of time. Microspheres with different densities were centrifuged together in the presence of 
10% serum to form scaffolds (we previously demonstrated that microspheres crosslink together in the 
presence of serum proteins to form solid materials) (E. a. Scott et al., 2010). The distribution of the 
fluorescent dyes in the scaffold was visualized using a scanning confocal fluorescence microscope. 
The scaffolds were formed in the bottoms of Pasteur pipettes. Each scaffold was about 2 cm 
long. The glass walls provided a good optical platform for the scanning confocal microscopy. 
However, early experiments showed substantial streaking of microspheres along the walls of the 
pipette. Evidently, some microspheres were adhering to the glass walls and not migrating properly. 
The presence of amines in the microspheres makes them net cationic, (Nichols et al., 2009) probably 
promoting adhesion to the anionic silanol groups on the glass. The glass was thus coated with PLL-g-
PEG to prevent the microspheres from adhering to the glass walls. This eliminated the streaking of 
microspheres and allowed the formation of distinct gradients. 
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We found that incubation of the PEG at 70 °C provided the greatest range and control of 
densities of the microspheres while keeping the polydispersity to a minimum. To demonstrate the full 
range of densities, a 2-tier scaffold was made using the highest and the lowest density microspheres 
(Fig. 2.4). The incubation times above the cloud point used to produce these two types of 
microspheres were 11 and 45 min. Times less than 11 min did not produce microspheres. Times 
greater than 45 min led to the aggregation of the microspheres into a gel-like structure. 
 
Next, we determined how many tiers with sharp interfaces could be produced in these 
scaffolds. The maximum number of clearly defined tiers of microspheres that we were able to form 
was three (Fig. 2.5). We previously showed a nonlinear relationship between density, and incubation 
time, with large changes in swelling (and presumably density) soon after microspheres begin to form, 
but with a long plateau with a slow rate of change in swelling at longer incubation times (Nichols et 
 
Figure 2.4. Two-tier gradient with sharp interface. Microspheres were formed above the cloud point at 
70˚C.  Dylight-488 (green) labeled microspheres were incubated above the cloud point for 45 minutes. 
Dylight-633 (blue) labeled microspheres incubated above the cloud point for 11 minutes.  (a) combined 
channels, (b) blue only, (c) green only. 
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al., 2009). Incubation times resulting in well-defined 3-tier gradient were 11, 17, and 45 min. If we 
tried to achieve more than 3 tiers, the tiers began to blend together. This blending, however, could be 
useful if gradual transitions between levels were desired, so we formed 5-tier gradients as well (Fig. 
2.6). The best incubation times for forming 5-tiered gradient scaffolds were 11, 12, 16, 26, and 45 
min. In this 5-tier gradient, the transitions from level to level became nearly seamless. 
 
Though this 5-tier gradient may provide great control over the form of the gradient, a simple 
2-tier gradient with a gradual transition between levels might also be desirable. At the standard 70 °C 
formation temperature, either two distinct layers or no detectable gradient were formed. Exploring 
another temperature (95 °C) resulted in more success. The higher temperature resulted in 
microspheres with densities different enough to separate into tiers but close enough to have a region 
with substantial overlap. We found the most successful incubation times at 95 °C for a gradual 
transition 2-tier gradient were 3 and 5 min (Fig.2.7). 
 
Figure 2.5. Three-tier gradient with sharp interfaces.  Microspheres were formed above the cloud point at 
70˚C.  Dylight-488 (green) labeled microspheres were incubated above the cloud point for 45 minutes. 
Dylight-549 (red) labeled microspheres were incubated above the cloud point for 17 minutes.  Dylight-633 
(blue) labeled microspheres were incubated above the cloud point for 11 minutes.  (a) combined channels, (b) 
blue only, (c) green only, (d) red only. 
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Figure 2.7. Two-tier gradient with gradual transition. Microspheres were formed above the cloud point at 
95˚C.  Dylight-488 (green) labeled microspheres were incubated above the cloud point for 5 minutes. Dylight-
633 (blue) labeled microspheres were incubated above the cloud point for 3 minutes.  (a) combined channels, 
(b) blue only, (c) green only. 
 
Figure 2.6. Five-tier gradient. Microspheres were formed above the cloud point at 70˚C.  Dylight-488 
(green) labeled microspheres were incubated above the cloud point for 12 or 45 minutes. Dylight-549 (red) 
labeled microspheres were incubated above the cloud point for 16 minutes.  Dylight-633 (blue) labeled 
microspheres were incubated above the cloud point for 11 or26 minutes.  (a) combined channels, (b) blue only, 
(c) green only, (d) red only. 
40 
 
2.4.2 Formation of Protein Gradients 
We are particularly interested in producing conduits for nerve regeneration, and GDNF has 
been shown to enhance motor nerve regeneration (Barras, Pasche, Bouche, Aebischer, & Zurn, 2002; 
Fine et al., 2002). To directly visualize the GDNF in the scaffolds, we fluorescently labeled the 
protein with Dylight-488. A simple 2-tier gradient of Dylight-488 labeled GDNF was made using the 
2-tier gradient scheme that produced sharp interfaces. The denser microspheres were formed in the 
presence of the fluorescently labeled proteins to promote covalent attachment. The less dense 
microspheres were labeled with Dylight-633 so that these microspheres could be visualized in the 
scaffold. Covalent coupling of proteins to one of the microsphere types did not affect gradient 
formation (Fig. 2.8). 
 
Due to the high temperature of microsphere formation (70 °C), the proteins were likely 
denatured. At physiological temperature, 37 °C, the only gradients that were produced were 2-tier 
gradients with gradual transitions between levels (Fig. 2.9). The incubation times above the cloud 
 
Figure 2.8. Two-tier gradient with covalently coupled BSA/GDNF. Microspheres were formed above the 
cloud point at 70˚C.  Dylight-488 (green) labeled BSA/GDNF was covalently coupled to PEG precursors 
during microsphere formation.  The PEG/protein microspheres were incubated above the cloud point for 45 
minutes.  Dylight-633 (blue) labeled microspheres were incubated above the cloud point for 3 minutes (no 
protein is coupled; dye is covalently coupled to PEG precursor).  (a) combined channels, (b) blue only, (c) 
green only. 
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point for forming the 2-tier gradient at physiological temperature were 20 and 65 min. As before, the 
denser microspheres were formed in the presence of the labeled protein to ensure covalent 
attachment, while the lighter microspheres were labeled with Dylight-633. 
 
2.4.3 Reversibly Bound Gradients 
An alternative to covalent bonding is to use heparin to promote electrostatic binding of 
heparin-binding proteins (Nie et al., 2007; Sakiyama-Elbert & Hubbell, 2000; Tae et al., 2006). 
Heparin-binding proteins potentially could be bound after microsphere formation, allowing 
microsphere formation at high temperatures, but eliminating the risk of protein denaturation. Non-
covalent coupling would also prevent the reduction in activity that covalent binding might cause. To 
attach heparin to the microspheres, we activated carboxyl groups on heparin with EDC and NHS and 
reacted this with PEG8-amine, similar to the chemistry used by Tae et al. (Tae et al., 2006). The 
microspheres were formed as before using the PEG8-amine with covalently coupled heparin at 70 °C 
 
Figure 2.9. Two-tier gradient with covalently coupled BSA/GDNF formed at 37°C. Microspheres were 
formed above the cloud point at 37˚C.  Dylight-488 (green) labeled BSA/GDNF was covalently coupled to 
PEG precursors during microsphere formation.  The PEG/protein microspheres were incubated above the 
cloud point for 65 minutes.  Dylight-633 (blue) labeled microspheres were incubated above the cloud point for 
20 minutes (no protein coupled, dye bound to PEG precursor).  (a) combined channels, (b) blue only, (c) green 
only. 
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or 95 °C, allowing the use of the most versatile gradient formation protocols. A 3-tier gradient of 
heparin-decorated microspheres with sharp interfaces is shown (Fig. 2.10). 
 
To demonstrate that the microspheres were indeed decorated with heparin, we performed a 
number of controls using Dylight-488 labeled protamine (a protein with very high affinity for 
heparin). Protamine bound to the formed PEG/heparin microspheres was shown to be non-covalently 
bound by eluting the protamine at elevated NaCl concentrations (Fig. 2.11). The denser PEG/heparin 
microspheres were incubated overnight with Dylight-488 labeled protamine and then spun down with 
lighter Dylight-633 labeled, PEG/heparin microspheres. A gradient of protamine was formed using 
the sharp, 2-tier gradient scheme (Fig. 2.12). 
 
 
Figure 2.10. Three-tier gradient with PEG/heparin microspheres.  Microspheres were formed above the 
cloud point at 70˚C using heparin-coupled PEG8-amine.  Dylight-488 (green) labeled microspheres were 
incubated above the cloud point for 45 minutes. Dylight-549 (red) labeled microspheres were incubated above 
the cloud point for 17 minutes.  Dylight-633 (blue) labeled microspheres were incubated above the cloud point 
for 11 minutes.  (a) combined channels, (b) blue only, (c) green only, (d) red only. 
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Figure 2.12. Two-tier gradient with electrostatically bound protamine. PEG-heparin microspheres were 
formed above the cloud point at 70˚C.  PEG-heparin microspheres were incubated above the cloud point for 45 
minutes.  Following buffer exchange into PBS, microspheres were incubated with Dylight-488 (green) labeled 
protamine.  Dylight-633 (blue) labeled PEG-heparin microspheres were incubated above the cloud point for 11 
minutes.  (a) combined channels, (b) blue only, (c) green only. 
 
Figure 2.11. High salt release of protamine. NaCl was added in various concentrations (0-2 M) to heparin 
decorated microspheres with Dylight-488 labeled protamine attached. After 40 hours the flourescence of the 
supernatant was measured to track the release of protamine compared to salt concentration (n=2 for each data 
point, mean and standard deviation reported for each).  
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2.5 Discussion 
Using differences in microsphere density, multiple-tier scaffolds were constructed with sharp 
or gradual transitions between levels. The 2-tiered scaffold with a gradual transition suggested the 
possibility to produce linear gradients in concentration of cell adhesion peptides/proteins, mechanical 
stiffness, growth factor/drugs, degradability, etc. Up to 5-tier gradients were possible. The degree to 
which a particular property is added to each tier could be controlled independently, such that 
exponential, parabolic, impulse, and many other gradient profiles may be imagined. In particular, a 
gradient might be chosen that balances the diffusion out of one or both ends of the scaffolds, 
producing zero order release (D. C. Scott & Hollenbeck, 1991). 
The microsphere gradients were easily produced; however, several challenges remain to 
translate these properties into a functioning growth factor delivery system. The best results were 
obtained with microspheres formed at 70 °C and 95 °C. At 37 °C, the widest possible range of 
incubation times above the cloud point resulted in density differences that could only produce a 2-
tiered gradient with a gradual transition. The mechanism for this was not determined, but we may 
speculate based on previous results. We previously demonstrated that following phase separation, the 
PEG-rich phases coarsen, or increase in size over time due to coalescence. At the gel point, 
coalescence is halted. Longer gelation times result in larger microspheres. The time to reach the gel 
point may be decreased by pre-reacting the PEG macromers prior to phase separation or by increasing 
temperature or pH. After gelation, the microspheres remain in the phase-separated state until buffer 
exchanged into PBS. After buffer exchange, crosslinking may continue, but is likely quite slow due to 
the lower concentration of PEG in the swollen gel. These are second order reactions, with the reaction 
rate scaling with the PEG concentration squared (note that the PEG8-vinylsulfone and PEG8-amine 
are not present at equal concentrations but the same scaling applies). Thus, the number of crosslinks 
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formed in the phase-separated state will be critical in determining the degree of swelling following 
buffer exchange. The relationship between crosslink density and swelling is described by the well-
known Flory–Rehner equation (Flory, 1953). However, we previously found that the decrease in 
swelling with increasing crosslinking time was not readily described in the Flory–Rehner framework 
other than qualitatively (Nichols et al., 2009). Intuitively, one would expect that soon after gelation, 
the number of crosslinks should increase rapidly. A large number of multiarm-PEGs with two arms 
attached to the network should be present at the gel point, which soon become crosslink sites after 
only one more arm attaches to the network (assuming all three arms are elastically active). Later on, 
however, the formation of crosslink sites will be slowed by steric hindrance. The general shape of the 
curve provides guidelines for selecting time points to achieve gradual transitions between tiers. Close 
to the gel point, the incubation times must be closely spaced because the density is changing rapidly. 
At longer times, the incubation times must be spaced further apart. If the incubation times are too 
close, no separation into layers will be observed, while if they are too far apart, a sharp interface will 
develop. We found that the production of a gradual transition between 2 tiers was most successful if 
the microspheres were formed at 95 °C. Gradual transitions may be observed in the 5-tier scaffold 
made from microspheres formed at 70 °C. However, 2-tiered gradients formed from these 
microspheres had a transition zone that did not extend throughout the scaffold (data not shown). Due 
to the shape of the curve that describes swelling as a function of incubation time, finding times that 
led to a near linear gradient in a 2-tiered scaffold may simply have required more trial-and-error, and 
we most likely were just fortunate to find appropriate times in the 95 °C case. We examined the size 
and polydispersity of microspheres qualitatively and did not observe a striking difference between 
those formed at 70 °C and 95 °C, eliminating this as a possible source for the observed difference in 
gradient formation. 
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Covalent immobilization at 37 °C will be necessary to prevent protein denaturation, but the 
range of densities that could be generated at this temperature was quite limited. Close examination of 
the confocal images revealed what appear to be large aggregates of microspheres. According to 
Stoke’s law, terminal velocity scales with radius squared, providing a mechanism for the aggregates 
to sediment more rapidly. The presence of aggregates may be related to the long incubation times. 
However, the aggregates appear to be present in the 37 °C microspheres that were incubated above 
the cloud point for only 20 min. Due to the slower reaction kinetics at 37 °C, the microspheres formed 
at this temperature were larger, likely due to a longer time to reach the gel point, despite the fact that 
the solutions were pre-reacted prior to phase separation. Aggregation may be related to microsphere 
size, as Stoke’s law also applies to the rising of the larger microspheres in the dense sodium sulfate 
solutions (‘creaming’). Aggregation thus may have been enhanced as microspheres concentrated near 
the top of the solution. Microsphere formation is performed in unstirred solutions to minimize 
coarsening prior to gelation, but this may also enhance aggregation of the formed microspheres that 
rise to the top of the solution. 
The current results suggest that microsphere formation at 70 °C or higher has distinct 
advantages. Notably, it appears that aggregation was minimized due to a combination of small 
microsphere size and shorter incubation times. For the delivery of growth factors and other proteins, 
post-loading of the proteins would be necessary. Yet, the small size of the microspheres may make 
post-loading somewhat difficult. The effective diffusion coefficient of heparin-binding proteins in the 
presence of immobilized heparin is simply, 
    1

P/B
D
D ABeffAB  
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where [P] is the concentration of free protein and [B] is the concentration of bound protein (Crank J., 
1975). In the presence of an excess of heparin-binding sites, this ratio is simply: 
 
 
 
DK
H
P
B
  
where [H] is the concentration of bound heparin. To decrease the effective diffusion coefficient, high 
affinity interactions or high concentrations of heparin are required. This becomes important due to the 
small size of the microspheres produced (less than 5 microns in diameter). With microspheres of this 
size, the time for equilibration with the surrounding solution is quite short (order of seconds). To 
reach a Fick number (mass transfer Fourier number) of τ = 0.5, representing about 99% equilibration 
between the microsphere and the surrounding medium, requires a time of t = τR2/DAB. A typical 
DAB for a heparin-binding growth factor (mol. wt. 20,000 Da) is 1.01 × 10−4 cm2/min (Maxwell, 
Hicks, Parsons, & Sakiyama-Elbert, 2005). With a KD of 3 × 10−7 m (Wacker et al., 2006) and a 
heparin concentration of 4.6 × 10−5 m calculated for these microspheres, the time to reach a Fick 
number of 0.5 is less than 3 s. After the microspheres are assembled into a scaffold, the appropriate 
length scale for diffusion is that of the scaffold and controlled release will occur of over much longer 
time periods. However, the rapid equilibration presents a challenge for forming gradients by 
centrifugation, which requires about 10 min. To overcome this limitation, the PEG/heparin 
microspheres were incubated with protamine, which has an extremely high binding affinity for 
heparin (Jaques, 1943; Jones, Hashim, & Power, 1986). However, the equations presented above 
provide a guidepost for engineering the system for growth factor delivery by non-covalent 
interactions. Another solution may be to incorporate high densities of positive or negative charges 
into the microspheres, such as are found in gelatin microspheres that are used for growth factor 
delivery (Morimoto et al., 2000; H. Park, Temenoff, Holland, Tabata, & Mikos, 2005). This may 
allow the attachment and controlled release of a variety of charged biological molecules. 
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2.6 Conclusions 
We have shown that various gradients can be fabricated by manipulating the densities of PEG 
microspheres. In particular, the 5-tier gradient could be used to make a wide variety of complex 
profiles, while the gradual 2-tier gradient provided a fast and simple way of forming a linear gradient. 
Using these techniques, a 2-tier sharp gradient in GDNF was produced. A somewhat linear gradient in 
GDNF/BSA was formed with microspheres fabricated at a physiological temperature. Heparin was 
bound to the microspheres to promote attachment of heparin-binding molecules post-microsphere 
formation. The heparin microspheres formed gradients as before, and a 2-tiered gradient in protamine 
was produced. With further engineering, this system may be useful for the development of a variety 
of gradients in PEG-based scaffolds. 
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Chapter 3* 
Controlled release and gradient formation of 
human glial-cell derived neurotrophic factor 
from heparinated poly(ethylene glycol) 
microsphere-based scaffolds 
 
3.1 Abstract 
Introduction of spatial patterning of proteins, while retaining activity and releasability, is 
critical for the field of regenerative medicine. Reversible binding to heparin, which many biological 
molecules exhibit, is one potential pathway to achieve this goal. We have covalently bound heparin to 
poly(ethylene glycol) (PEG) microspheres to create useful spatial patterns of glial-cell derived human 
neurotrophic factor (GDNF) in scaffolds to promote peripheral nerve regeneration. Labeled GDNF 
was incubated with heparinated microspheres that were subsequently centrifuged into cylindrical 
scaffolds in distinct layers containing different concentrations of GDNF. The GDNF was then 
allowed to diffuse out of the scaffold, and release was tracked via fluorescent scanning confocal 
microscopy. The measured release profile was compared to predicted Fickian models. Solutions of 
reaction–diffusion equations suggested the concentrations of GDNF in each discrete layer that would 
result in a nearly linear concentration gradient over much of the length of the scaffold. The agreement 
between the predicted and measured GDNF concentration gradients was high. Multilayer scaffolds 
*
 Chapter 3 has been adapted from the following manuscript:  
J. Roam, P. Nguyen, D. Elbert. Controlled release and gradient formation of human glial-cell 
derived neurotrophic factor from heparinated poly(ethylene glycol) microsphere-based scaffolds. 
Biomaterials, 35 (2014), pp. 6473–6481. 
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with different amounts of heparin and GDNF and different crosslinking densities allow the design of 
a wide variety of gradients and release kinetics. Additionally, fabrication is much simpler and more 
robust than typical gradient-forming systems due to the low viscosity of the microsphere solutions 
compared to gelating solutions, which can easily result in premature gelation or the trapping of air 
bubbles with a nerve guidance conduit. The microsphere-based method provides a framework for 
producing specific growth factor gradients in conduits designed to enhance nerve regeneration.  
3.2 Introduction 
 The importance of gradients in biological molecules is well recognized. Processes such 
as nerve regeneration, wound healing, embryogenesis, angiogenesis, and immunity have been found 
to depend significantly on biological gradients (X. Cao & Shoichet, 2001; DeLong et al., 2005; Fisher et 
al., 1989; Kapur & Shoichet, 2004; Knapp et al., 1999; K. Moore et al., 2006; Parent & Devreotes, 1999; 
Rosoff et al., 2004; Singh et al., 2008; H. Song  & Poo , 2001; H. J. Song et al., 1997; X. Wang et al., 2009).  
In chemotaxis cells follow concentration gradients in signaling molecules, with the steepness of the 
gradients greatly influencing cell movement more than the average concentration (Knapp et al., 1999; 
K. Moore et al., 2006; Parent & Devreotes, 1999).  To replicate and improve upon developmental and 
repair processes to engineer tissues and organs, production of bioactive gradients along with spatial 
patterning will be essential.   
In recent years an increasing number of researchers have proposed many methods to this end 
(Campbell et al., 2005; Chung et al., 2009; Cosson et al., 2009; Dodla & Bellamkonda, 2008, 2006; 
Dormer et al., 2010; J. He et al., 2010; Kipper et al., 2007; Lühmann et al., 2009; Mapili et al., 2005; 
Oh et al., 2011; Roam et al., 2010; Stefonek & Masters, 2007; Vepari & Kaplan, 2006; X Yu et al., 
1999; Zaari et al., 2004). For example, Khademhosseini and colleagues have created gradients in 
adhesion peptides using inverse flows and photopolymerization in microfluidic channels to influence 
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and study endothelial cell migration (J. He et al., 2010).  Shoichet, et al. have immobilized nerve 
growth factor in concentration gradients and observed enhanced directionality of extending dendrites 
(Kapur & Shoichet, 2004; Luo & Shoichet, 2004; K. Moore et al., 2006).  Bellamkonda, et al. found 
increasing concentration gradients in laminin-1 could alter the direction of growing dorsal root 
ganglia and enhanced regeneration of sciatic nerves in rats with nerve growth factor (Dodla & 
Bellamkonda, 2008, 2006; Vepari & Kaplan, 2006).  
Many of the current methods for the patterning and delivery of bioactive molecules use 
various forms of covalent attachment (Campbell et al., 2005; Cosson et al., 2009; Kipper et al., 2007; 
Lühmann et al., 2009; X Yu et al., 1999; Zaari et al., 2004).  Irreversible coupling, however, may not 
be the optimal approach.  Covalent attachment can potentially hinder the ability of cells to access the 
molecules, and chemical modification may result in a loss of activity.  An alternative that our lab has 
explored recently is the use of heparin-decorated synthetic materials that can bind electrostatically 
(reversibly) many useful proteins, including proteins that promote nerve regeneration (Jaques, 1943; 
Jones et al., 1986; Maxwell et al., 2005; Nie et al., 2007; Oh et al., 2011; Roam et al., 2010; 
Sakiyama-Elbert & Hubbell, 2000; Stefonek & Masters, 2007; Tae et al., 2006).  GDNF, a heparin 
binding protein, has been shown to enhance motor and sensory nerve regeneration (Barras et al., 
2002; Fine et al., 2002).  Synthetic polymer hydrogels have been extensively explored to create 
scaffolds for regenerative medicine, and have seen some promising results (Drury & Mooney, 2003; 
Nichols et al., 2009; Tessmar & Göpferich, 2007).  Functional peptides, proteins, or other biological 
molecules like heparin may be incorporated into these hydrogels imparting biological functions, such 
as cell adhesion or cell-initiated degradability (Almany & Seliktar, 2005; DeLong et al., 2005; M P 
Lutolf & Hubbell, 2005; E. a. Scott et al., 2010; Zhang et al., 2006).  However, bulk hydrogel 
scaffolds generally lack macroporosity or spatial anisotropy. To address these limitations we and 
others are seeking to produce heterogeneous scaffolds using modular assembly of hydrogel 
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microparticles (Boland et al., 2006; Khademhosseini & Langer, 2007; Liu Tsang & Bhatia, 2004; 
Rivest et al., 2007; Roam et al., 2010; E. a. Scott et al., 2010; Um et al., 2008; Yeh et al., 2006).   
Gradient producing systems such as pulsatile application of picoliters of growth factor 
solutions, simple diffusion of molecules into a gel, gradient makers using two polymerizing solutions, 
and microfluidic devices have been used extensively (X. Cao & Shoichet, 2001; Chung et al., 2009; J. 
He et al., 2010; Kapur & Shoichet, 2004; Knapp et al., 1999; H. J. Song et al., 1997; Stefonek & 
Masters, 2007).  However scaling issues and difficulties in pumping polymerizing solutions are only a 
few of the challenges faced by these methods due to the low volumes involved (e.g. about 70 µL of 
fluid per centimeter of conduit).  The formation of gradients of growth factors, as well as addition of 
adhesion factors and degradibility in bioactive scaffolds, is proposed to be improved by assembling 
microparticles in a modular manner (Du et al., 2008; Rivest et al., 2007; Roam et al., 2010; E. a. Scott 
et al., 2010; Serban & Prestwich, 2008; Yeh et al., 2006).  To this end our lab has developed PEG 
hydrogel microspheres fabricated from multi-arm PEG derivatives in aqueous solution with 
kosmotropic salts via a thermally induced phase separation (Roam et al., 2010; E. a. Scott et al., 
2010).  This is a novel strategy in that solutions are not mixed during microsphere formation, with 
size controlled by the length of time required for gelation (D. Elbert, Nichols, & Scott, 2013). We 
have already successfully imparted different functionalities, such as cell adhesion, degradability, 
heparination, and protein and drug delivery to these microspheres (Roam et al., 2010; E. a. Scott et 
al., 2010).   
In a recent study we engineered gradients into scaffolds made from these PEG microspheres, 
most notably decorating the microspheres with heparin and creating a gradient of covalently coupled 
GDNF (Roam et al., 2010).  However, we had not demonstrated the release of electrostatically (i.e. 
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reversibly) bound GDNF from these scaffolds. The challenges in the previous publication that did not 
allow release of GDNF were overcome and the results are presented here.   
3.3 Materials and Methods 
Unless otherwise noted, all reagents were purchased from Sigma–Aldrich. 
 
3.3.1 PEG Synthesis  
PEG8-vinylsulfone (PEG8-VS) and PEG8-amine was synthesized from eight-arm PEG-OH 
(PEG8-OH; mol. Wt. 10,000; Shearwater Polymers, Huntsville, AL) as previously described (Wacker 
et al., 2006).  PEG macromonomers were dissolved separately at 200 mg/mL in Dulbecco’s 
phosphate buffered saline (PBS; 8 mM sodium phosphate, 2 mM potassium phosphate, 140 mM 
sodium chloride, 10 mM potassium chloride, pH 7.4) and sterile filtered with 0.22 μm syringe filters 
(Millipore).   
3.3.2 Heparin Attachment 
A solution of 500 mM N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC), 12.5 mM N-Hydroxy-succinimide (NHS), and 50 mg/mL heparin sodium salt (mol. wt. 
~18,000, ~2.78 mM) in MES buffer (10 mM, pH 6.0) was incubated at room temperature for 30 min.  
The activated heparin solution was then added to a 200 mg/mL solution of PEG8-amine at a 20:1, or 
160:1 PEG8-amine to heparin molar ratio and incubated at room temperature for another 30 min 
before refrigeration.  For microsphere formation, heparin-conjugated PEG8-amine was mixed with 
PEG8-VS in a 1:2 ratio of the two PEG types (see Figure 3.1). 
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3.3.3 Microsphere Formation 
PEG8-amine (with or without bound heparin) solutions were combined with PEG8-VS 
solutions at a 1:2 ratio. The PEG solutions were diluted to 20 mg/mL PEG with PBS and 1.5 M 
sodium sulfate (in PBS) to a final sodium sulfate concentration of 0.6 M.  The PEG8-VS/PEG8-amine 
solutions were then incubated above the cloud point at 70˚C for various times.  Suspensions of 
microspheres were subsequently buffer exchanged into 8 mM sodium phosphate twice to remove the 
sodium sulfate by: (1) diluting the microsphere solution 3:1 with PBS and titurating, (2) centrifuging 
at 14,100g for 2 min, and (3) removing the supernatant.  
3.3.4 GDNF  Labeling 
Dylight-488 NHS-ester (Pierce) was dissolved in dimethyl formamide at 10 mg/mL.  
Recombinant human GDNF (Peprotech, Rocky Hill, NJ) was dissolved in 8 mM sodium phosphate 
 
Figure 3.1. Heparin Attachment 
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buffer (pH 7.4).  Dylight-488 was added to the solution for a final GDNF concentration of 10 μg/mL 
and a final Dylight-488  concentration of 50 ng/mL and incubated overnight at 2˚C.  The solution was 
then dialyzed using Slide-A-Lyzer MINI Dialysis Units (Thermo Scientific, Rockford, IL, 3500 
MWCO) in 8 mM sodium phosphate buffer (pH 7.4) to remove unbound Dylight-488.   
3.3.5 Heparin labeling 
For some experiments, heparin was labeled with Dylight-488.  A solution of heparin (100 
mg/mL) and Dylight-
labeled heparin solution was dialyzed using Slide-A-Lyzer MINI Dialysis Units in MES buffer (10 
mM, pH 6.0) to remove any unbound Dylight-488.  The heparin solution was then used in the 
microsphere formation protocol as described above. 
3.3.6 GDNF Loading of Heparin Microspheres 
Labeled or unlabeled GDNF solutions were added to buffer washed microspheres such that 
the GDNF concentration within the supernatant was 250 ng/mL.  The microsphere/GDNF solution 
was well mixed, by tituration and incubated overnight to allow diffusion of the GDNF into the 
microspheres.  Immediately before scaffold formation, the microspheres were centrifuged at 14,100 g, 
supernatant was removed, and microspheres were resuspended in 8 mM sodium phosphate.  
3.3.7 Gradient Formation 
The glass walls of Pasteur pipettes were passivated with PLL(375)-g[7]-PEG(5) (D. L. Elbert 
& Hubbell, 1998; Kenausis et al., 2000).  The pipettes were filled with a 20 mg/mL PLL-g-PEG 
solution, incubated for 30 seconds, and washed with DI water.  After sufficient drying time, the tips 
of the pipettes were sealed with silicone aquarium sealant (DAP Inc., Baltimore, MD).  To form 
scaffolds, microsphere solutions loaded or unloaded with GDNF were sequentially added to the 
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pipettes that were placed in 15 mL conical vials.  The microsphere solutions were centrifuged at 1000 
g for 5 min before the next layer of microspheres was added (Figure 3.2).  The supernatant was then 
removed once more and replaced with either 8 mM Sodium Phosphate or PBS. 
 
3.3.8 Confocal Microscopy 
Fluorescence microscopy was performed with a Nikon Eclipse C1/80i confocal microscope.  
Microsphere gradients were imaged while still in the Pasteur pipettes with a 10X objective (NA=0.30, 
DIC L/N1, WD= 16.0mm).  Multiple images were taken along the length of the pipette and processed 
using EZ-C1 3.70 FreeViewer software (Nikon Instruments Inc.) and then combined.  Fluorescence in 
the composite photographs was analyzed with ImageJ software. 
 
Figure 3.2. Gradient formation. (a) Batches of microspheres with similar chemical structures but varying 
amount of GDNF and/or heparin were created separately.  One batch of  microspheres were buffer exchanged 
to 8mM sodium phosphate buffer (pH 7.4) and immediately added to a PLL-g-PEG treated Pasteur pipette. (b) 
After centrifugation for 5 min at 1000 g, a second batch of different microspheres were added , and (c) Upon a 
second centrifugation, the microspheres formed two distinct layers.  
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3.4 Results and Discussion 
3.4.1 Conformation of Heparin Attachment 
To confirm attachment of heparin to PEG-OAm and subsequent incorporation into 
microspheres, heparin was labeled with Dylight-488.  The mechanism to couple the NHS ester dye to 
heparin was conceived because of an observation that NHS-activated heparin alone will form a gel if 
the reaction is allowed to proceed overnight.  Crosslinking was most likely due to reactions between 
the NHS-esters on heparin and secondary amines on heparin, although the concentration of this 
chemical linkage was too low to measure by NMR or IR.  Though Dylight-488 normally reacts with 
primary amines, adequate incubation time allowed for reaction with heparin.  Unreacted Dylight-488 
was removed by dialysis as well as by the washing steps after microsphere formation (by which time 
the NHS-esters on Dylight-488 would be hydrolyzed and unreactive).  After the washes, the 
microspheres were photographed with a fluorescence microscope (Figure 3.3A).  The total 
fluorescence was also compared to unlabeled heparin microspheres on a fluorescence plate reader to 
confirm the fluorescence was originating from the labeled heparin (Figure 3.3B).  Fluorescence 
readings were also taken on the labeled heparin microspheres before and after the washing steps.  The 
washed microspheres contained 46% of the fluorescence of the unwashed microspheres.  This 
indicated that at most 46% of the heparin was successfully integrated into the microspheres. 
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3.4.2 Step Gradients 
We previously presented a method of gradient formation in one step, using density (buoyancy) 
differences in microspheres to form distinct layers during centrifugation (Roam et al., 2010). 
However, we suspected that differences in crosslink density that resulted in differences in buoyancy 
may affect rates of growth factor diffusion within the microspheres.  To test this, scaffolds were made 
from microspheres crosslinked for 11 minutes or 45 minutes.  We had shown that these crosslinking 
times resulted in the full range of practically achievable buoyancies (less crosslinking time did not 
result in microsphere formation and more resulted in substantial microsphere aggregation) (Roam et 
al., 2010).  Single-layer scaffolds were prepared from each microsphere type in the presence of 250 
ng/mL Dylight-labeled GDNF.  The interface between the microsphere layer and the supernatant was 
imaged immediately after scaffold formation (i.e. before removing the supernatant and washing the 
scaffold).  Representative fluorescent images are shown in Figure 3.4, which suggest that the scaffold 
made from microspheres incubated in the phase separated state for only 11 minutes had higher GDNF 
concentrations than the adjacent supernatant. The opposite was true for a scaffold made from 
 
Figure 3.3. Confirmation of Heparin Attachment (A) Photomicrograph of PEG microspheres decorated 
with Dylight-488 labeled heparin. (20X)  (B) Fluorescence of microspheres with labeled and unlabeled 
heparin. Excitation 488nm, Emission 530nm. (n=3, error bars shown) 
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microspheres incubated in the phase separated state for 45 minutes (the highest crosslinking density 
possible without substantial microsphere aggregation) (Roam et al., 2010). This indicated that the 
more densely crosslinked microsphere had a restricted ability to absorb GDNF. Although a one-step 
process for gradient formation is attractive, the non-uniformity in growth factor diffusion rates for the 
different layers makes prediction of release kinetics extremely challenging. Thus, we subsequently 
used the lowest crosslinking time (11 minutes) for all microspheres to ensure high loading of growth 
factor in the scaffolds and predictability of release kinetics.  Gradient scaffolds were thus formed by 
sequentially centrifuging microspheres in distinct layers, with gradients formed by incubating 
microspheres with different concentrations of GDNF prior to and during centrifugation.  The layer-
by-layer scaffold formation method served to eliminate the high sensitivity of the microsphere 
structure to the length of incubation time in the phase separated state during microsphere formation.  
Although the layer-by-layer method initially produces step gradients in GDNF, continuous gradients 
of soluble GDNF are rapidly generated by diffusion and dynamic interactions with heparin in the 
scaffold.   
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3.4.3 Linear Gradient Formation from Initial Step Gradients 
Figures 3.5 and 3.6 show release for single tiered scaffolds made of heparin-containing 
microspheres incubated in 250 ng/mLGDNF during scaffold formation.  Figures 3.7 and 3.8 show 
scaffolds with two tiers - a lower tier with scaffold made of heparin-containing microspheres 
incubated in 250 nM GDNFduring centrifugation, and an upper level with no GDNF present during 
centrifugation of heparin-containing microspheres.  Figures 3.5A, 3.6A, 3.7A, and 3.8A demonstrate 
GDNF gradient formation within one or two tier scaffolds, with release into either physiological 
(Figures 3.5 and 3.7) and low salt conditions (Figures 3.6 and 3.8).  The affinity of GDNF for heparin 
in the microspheres will be influenced by the concentration of salt in the surrounding buffer (Roam et 
al., 2010).  Low salt (8mM sodium phosphate) should result in slower release than physiological salt 
concentrations (i.e. PBS).    More rapid release of GDNF into buffer at physiological salt 
concentration was observed, as expected, which was quantified in Figures 3.5B, 3.6B, 3.7B and 3.8B.  
 
Figure 3.4. Microsphere Displacement of GDNF. Photomicrographs of Dylight-488 labeled GDNF on the 
boundaries of scaffolds made from PEG microspheres (A) incubated 11 minutes and (B) incubated 45 minutes.  
Scaffolds are located to the left of the red line while the supernatant lies to the right. 
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Each of these figures also contains mathematical predictions for the GDNF concentration 
profile within the scaffold based on Fick’s 2nd Law (Figures 3.5C, 6C, 3.7C and 3.8C).  The 
prediction was obtained using a model that utilized an effective diffusion constant for GDNF within 
the scaffold: 
  1/ 

D
AB
eff
KH
D
D  
where Deff = effective diffusion constant, DAB =diffusion constant of GDNF in PEG scaffolds 
without heparin, [H] = heparin concentration, KD = equilibrium dissociation constant for the 
interaction of heparin with GDNF (Crank J., 1975).  Use of an effective diffusion coefficient is 
justified when binding equilibrium is rapidly achieved compared to the rate of diffusion.  The 
constants used for the predictions (DAB, KD) were initially estimated using literature values for 
diffusion of proteins of similar size through collagen gels (DAB = 7x10-7 cm2 s-1) and interaction of 
GDNF with heparin at physiological salt concentration (KD = 1x10-7 M).  (Saltzman, Radomsky, 
Whaley, & Cone, 1994; Wood, Borschel, et al., 2009).  From these values, Deff was predicted to be 
 
Figure 3.5. Release from 1-Tier Scaffold in Physiological Salt.  Physiological salt (PBS) release of Dylight-
488 labeled GDNF (constant initial profile) from Heparin decorated PEG microsphere (11 minute incubation)  
scaffold. (A) Composite photograph of fluorescence (GDNF) in scaffold at the zero time point, one day, and 5 
days. (B) Graphical depiction of fluorescence (GDNF concentration) vs. the distance in the scaffold for the 
three time points: zero (blue), 1 day (green), and 5 days (red). n=3 sample error bars shown. (C) Plot of 
predicted release (GDNF Concentration vs. distance in the scaffold) based on Fick’s 2nd law.  Zero time point 
(blue), 1 day (green), and 5 days (red). 
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1.52x10-7 cm2 s-1.  However, the rate of diffusion through these PEG hydrogels may be much slower 
than in a collagen gel.  Thus, the release data in Figures 3.5 through 3.8 were fit to solutions of Fick’s 
second law to determine best fit effective diffusion coefficients.  In physiological salt we observed a 
Deff = 4.84x10-8 cm2 s-1, while in low salt we observed Deff = 2.52x10-8 cm2 s-1.  The differences 
may be explained by the higher affinity of GDNF for heparin in low salt conditions.  All predicted 
curves in Figures 3.5 through 3.8 use these values for the effective diffusion coefficients.   
 
Figure 3.5 shows the high salt release for a single tiered scaffold made of microspheres 
incubated in 250 ng/mLGDNF during scaffold formation.  Reasonable agreement was observed 
between the predicted release profile and the measured release profile.  The low salt release for the 
same initial single-tiered profile (Figure 3.6) also was markedly similar to the predicted release 
profile.  Although the predicted release profile used an effective diffusion coefficient that was 
partially determined from this data, subsequent results will show that these same effective diffusion 
coefficients are able to describe release from a variety of scaffolds.  As expected, release was much 
slower into low salt buffer than high salt buffer.   
 
Figure 3.6. Release from 1-Tier Scaffold in Low Salt.  “Low salt” (8 mM Sodium phosphate) release of 
Dylight-488 labeled GDNF (constant initial profile) from Heparin decorated PEG microsphere (11 minute 
incubation)  scaffold. (A) Composite photograph of fluorescence (GDNF) in scaffold at the zero time point, 
one day, and 5 days. (B) Graphical depiction of fluorescence (GDNF concentration) vs. the distance in the 
scaffold for the three time points: zero (blue), 1 day (green), and 5 days (red). n=3 sample error bars shown. 
(C) Plot of predicted release (GDNF Concentration vs. distance in the scaffold) based on Fick’s 2nd law.  Zero 
time point (blue), 1 day (green), and 5 days (red). 
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3.4.4 Analysis of Gradients 
Table 3.1 presents an analysis of linearity of the graphs in Figures 3.5 through 3.8.  Linear 
regressions were performed on both experimental and predicted curves (excluding zero time points), 
 
Figure 3.8. Release from 2-Tier Scaffold in Low Salt.  2-tier initial profile, “low salt” (8 mM sodium 
phosphate) release of Dylight-488 labeled GDNF from Heparin decorated PEG microsphere (11 minute 
incubation)  scaffold. (A) Composite photograph of fluorescence (GDNF) in scaffold at the zero time point, 
one day, 5 days, and 12 days. (B) Graphical depiction of fluorescence (GDNF concentration) vs. the distance 
in the scaffold for the four time points: zero (blue), 1 day (green), 5 days (red), and 12 days (light blue). n=3 
sample error bars shown. (C) Plot of predicted release (GDNF Concentration vs. distance in the scaffold) 
based on Fick’s 2nd law.  Zero time point (blue), 1 day (green), 5 days (red), and 12 days (light blue). 
 
Figure 3.7. Release from 2-Tier Scaffold in Physiological Salt.  2-tier initial profile, physiological salt 
(PBS) release of Dylight-488 labeled GDNF from Heparin decorated PEG microsphere (11 minute incubation)  
scaffold. (A) Composite photograph of fluorescence (GDNF) in scaffold at the zero time point, one day, 5 
days, and 12 days. (B) Graphical depiction of fluorescence (GDNF concentration) vs. the distance in the 
scaffold for the four time points: zero (blue), 1 day (green), 5 days (red), and 12 days (light blue). n=3 sample 
error bars shown. (C) Plot of predicted release (GDNF Concentration vs. distance in the scaffold) based on 
Fick’s 2nd law.  Zero time point (blue), 1 day (green), 5 days (red), and 12 days (light blue). 
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requiring that points at (or near) the open end(right end) be included in the regression (for examples, 
see Figure 3.9). This would correspond to the growth factor gradient that extending axons would 
sense. The percentage of the length of the scaffold that produced a regression with an r2 value above 
a particular value is reported. For the predicted curves, we set a constraint of r2≥0.995 for the linear 
regression. Because the experimental curves contained experimental error, we set a constraint of 
r2≥0.95 for those regressions.  It should be clear that the purpose of the linear regression is to 
characterize the morphology of the curve and not to explain the relationship between the measured 
and predicted curves.  These values for the coefficient of determination produced similar percentages 
of the scaffolds with ‘linear’ GDNF concentration gradients (mostly below 50%) for the 1 tier 
scaffolds.  Scaffolds with two tiers had consistently larger percentages of the scaffold with ‘linear’ 
gradients, in both the experimental and predicted curves.   
 
 
Table 3.1. Linearity Comparisons.  Linearity  comparisons between  experimental and predicted models. 
Shown are the percentages of the length of the scaffolds with a linear regression which yielded a coefficient 
of determination above a particular threshold are shown (exp: R
2≥0.95, pred: R2≥0.995), corresponding to 
correlation coefficients of 0.975 and 0.9975, respectively.  Experimental (Exp) and predicted data (Pred) 
are shown for comparison.  The line was required to include points at (or near) the open (right) end of the 
scaffolds. It should be understood that the coefficients of determination are used here to describe the 
morphology of the curve and not to explain the underlying relationships between the measured 
concentration profile and the predicted values. Sample linear regions are shown in Figure 3.9. 
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For the 1 tier scaffold, the linearity varied greatly from 1 to 5 days in both experimental and 
both experimental and predicted cases, though the experiments have the surprising distinction of 
producing larger linear regions earlier and losing them over time as opposed to the model slowly 
growing more linear.   
 
For the 2 tier scaffolds, the experimental profiles show larger linear regions that their 
predicted counterparts for all time points, though the 1 day profiles show the greatest disparity, with 
all or nearly all of the experimental profiles showing high linearity while the model predicts less than 
 
Figure 3.9. Sample Linear Regions for Table 3.1. Shown are linear regressions over the portion of each 
concentration profile which yielded a coefficient of determination above a particular threshold (exp: 
R
2≥0.95, pred: R2≥0.995), corresponding to correlation coefficients of 0.975 and 0.9975, respectively.  The 
percentage of length of the scaffold (x axis) that each section spanned is reported in Table 3.1.  As in 
previous figures green, red, and blue lines correspond to 1, 5, and 12 days post-scaffold formation, 
respectively. 
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25%. The presence of a linear gradient in GDNF concentration that emerges in just one day and is 
maintained for 12 days with only two tiers suggests that this strategy is highly promising for 
generating growth factor gradients within scaffolds.  Furthermore, because of the high degree of 
predictability, more complex layer-by-layer arrangements may allow for the engineering of not only 
release kinetics but also gradient shape.  
3.4.5 Multi-Tier Scaffolds 
To demonstrate the robustness of this technique, multiple tiered scaffolds were fabricated with 
different amounts of GDNF in the tiers.  Figure 3.10 shows three and four-tiered scaffolds with 
GDNF initially in alternating tiers. These scaffolds are the same length of their simpler counterparts 
and thus the tiers are smaller becoming much more homogenous in GDNF concentration after only a 
day.  However, the intial GDNF concentration profile still strongly affects the resulting concentration 
profile at 1 day.  These examples display the ability of this method to create more complex GDNF 
concentration profiles and release kinetics.  The multiple tiers could also potentially be incubated with 
distinct concentrations of different growth factors, allowing release of multiple growth factors with 
different concentration profiles and release kinetics.  
67 
 
 
3.4.6 Heparin Variations within Scaffolds 
The heparin content in the different tiers can also be varied to affect the release kinetics and 
gradient-forming capabilities of the scaffolds.  Figures 3.11 and 3.12 show two cases where the top 
tier had a lower concentration of heparin than the bottom tier.  The bottom tier for both experiments 
had the original amount of heparin (20:1 PEG-OAm to heparin) while the second tier contained either 
no heparin (Figure 3.11) or 1/8 of the original heparin concentration (160:1 PEG-OAm to heparin; 
Figure 3.12).  In both cases, the microspheres were incubated overnight with 250 ng/mL GDNF.  A 
major caveat is that the microspheres with less heparin were considerably less dense than their fully 
heparinated counterparts, and the photomicrographs clearly indicate that the microspheres with less 
heparin absorbed more GDNF during incubation.  Thus, the top tier is initially much brighter than the 
bottom tier, so much so that the gain on the photodetector had to be greatly reduced below typical 
values.  By one day, the brightness of the top tier was dramatically decreased, allowing the gain to be 
returned to normal values.  The model predicted that with a higher initial GDNF concentration in the 
 
Figure 3.10. Multi-Tier Formations. The versatility of this gradient formation technique is displayed by 
three scaffolds with more complex patterns of GDNF. Composite photographs of fluorescence (GDNF) in the 
scaffolds taken at the zero time point and after one day.  (A) 3-tier initial pattern: GDNF-Empty-GDNF.  (B) 
3-tier initial pattern: Empty-GDNF-Empty. (C) 4-tier initial pattern: GDNF-Empty-GDNF-Empty.  
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top layer, rapid release of GDNF from the top of the scaffold would be combined with diffusion into 
the bottom layer, creating a maximum in the GDNF concentration profile at one day.  Although not as 
dramatic as predicted, this maximum in GDNF concentration was observed for both cases (Figures 
3.11 and 3.12).  These experiments illustrated that heparin concentration and microsphere crosslink 
density are both variables that can be adjusted to control the rate of release and the shape of the 
growth factor gradient over time. Ideally, methods would be developed in the future such that the 
heparin concentration did not affect the crosslink density. 
 
 
Figure 3.11. Release from 2-Tier Heparin/No Heparin Scaffold.  PEG microsphere (11 minute incubation) 
scaffold with first half (d<0.5 cm) made with 20:1 PEG-Oam to Heparin and the second half (d>0.5 cm) made 
without heparin, releases Dylight-488 labeled GDNF (constant initial profile) under “low salt” (8 mM Sodium 
phosphate) conditions. (A) Composite photograph of fluorescence (GDNF) in scaffold at the zero time point, 
one day, and 5 days. (B) Graphical depiction of fluorescence (GDNF concentration) vs. the distance in the 
scaffold for the three time points: zero (blue), 1 day (green), and 5 days (red). (C) Plot of predicted release 
(GDNF Concentration vs. distance in the scaffold) based on Fick’s 2nd law.  Zero time point (blue), 1 day 
(green), and 5 days (red).  
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3.4.7 GDNF Preservation 
A key consideration that must be addressed is whether or not the GDNF loses activity through 
this extensive incubation, scaffold formation, and subsequent release process.  Due to significant 
dilution into the release medium, the concentration of GDNF was too low to test with cells, although 
subsequent studies will test the response of chick dorsal root ganglion cells within the scaffolds.  For 
the current study, we asked if human GDNF retained its immuno-reactivity via ELISA measurements 
on the release solution.  Results showed, approximately 8% of the initial activity introduced into the 
microspheres was released from a microsphere pellet after one day.  A Matlab simulation of this 
process predicts a 55% release after 1 day.  Adsorption to the various surfaces and the loss of activity 
overnight loading and one day of release may account for the difference between the model prediction 
and the measured activity.  Further testing is required, but the retention of some GDNF immune-
reactivity suggests the possibility for the retention of some biological activity in the released GDNF. 
 
 
Figure 3.11. Release from 2-Tier Heparin/Heparin (1/8) Scaffold.  PEG microsphere (11 minute 
incubation) scaffold with first half (d<0.5 cm) made with 20:1 PEG-Oam to Heparin and the second half 
(d>0.5 cm) made with 160:1 PEG-Oam to Heparin, releases Dylight-488 labeled GDNF (constant initial 
profile) under “low salt” (8 mM Sodium phosphate) conditions. (A) Composite photograph of fluorescence 
(GDNF) in scaffold at the zero time point, one day, and 5 days. (B) Graphical depiction of fluorescence 
(GDNF concentration) vs. the distance in the scaffold for the three time points: zero (blue), 1 day (green), and 
5 days (red). (C) Plot of predicted release (GDNF Concentration vs. distance in the scaffold) based on Fick’s 
2
nd
 law.  Zero time point (blue), 1 day (green), and 5 days (red). 
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3.5 Conclusions 
 We devised robust methods for the creation of concentration gradients in GDNF.  
Through the sequential centrifugation of heparinated PEG microspheres loaded with varying amounts 
of GDNF, we quickly formed gradients in GDNF concentration.  With relatively uncomplicated two-
tiered scaffolds, linear gradients were produced and maintained for 12 days. The gradient shapes and 
kinetics agreed with mathematical predictions.  We showed that the production of more complex 
gradients is possible and that microsphere characteristics, such as crosslink density and heparin 
content, can be tuned to alter release kinetics.  This method of scaffold formation may be useful to 
improve nerve regeneration through engineered nerve guidance conduits. 
  
71 
 
Chapter 4 
A Modular, Plasmin-Sensitive, Clickable 
Poly(ethylene glycol)-Heparin-Laminin 
Microsphere System for Establishing 
Growth Factor Gradients in Nerve 
Guidance Conduits 
 
4.1 Abstract 
 Peripheral nerve regeneration is a complex problem that, despite many advancements and 
innovations, still has sub-optimal outcomes.  Though biological techniques using nerve grafts and 
autographs are promising, completely synthetic nerve guidance conduits (NGC), which allow for 
precise engineering of their properties, are a far more intriguing proposition.  One such property we 
have focused on is the introduction of spatial patterning of proteins, specifically glial-cell derived 
human neurotrophic factor (GDNF), which promotes nerve growth. We have created scaffolds made 
up of poly(ethylene glycol) (PEG) microspheres which form concentration gradients in reversibly 
bound GDNF.  To facilitate nerve extension, we have engineered microspheres with tunable plasmin 
degradability, CLICK cross-linking chemistries, cell adhesion via laminin, and heparin binding.  
GDNF released from these microspheres was confirmed to have retained its activity.  Methods for 
fabricating these scaffolds inside silicone conduits were developed using 3D printed molds.  The fully 
formed NGC’s contained degradable polymer scaffolding with linear gradients in reversibly bound 
GDNF.  These NGC’s were implanted into rats with severed sciatic nerves to confirm in vivo 
degradability and demonstrate that they do not elicit any negative biological responses. 
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4.2 Introduction 
 The treatment of peripheral nerve injury has advanced greatly in recent years. However, 
complete functional recovery continues to be difficult to achieve, suggesting it is critical that 
alternatives to the current standard of care (nerve autografts) be developed (Beazley, Milek, & Reiss, 
1984; Dellon & Mackinnon, 1988; Wood et al., 2010). A promising strategy involves the use of nerve 
guidance conduits (NGCs), which can be filled with synthetic and/or biological matrices along with 
growth factors, to span nerve gaps and enhance axonal regeneration (Schmidt & Leach, 2003).  Glial-
derived neurotrophic factor (GDNF) has been reported by several studies to be the most potent motor 
neuron trophic and survival factor, showing great promise in the treatment of peripheral nerve injuries 
(Henderson et al., 1993;  a Höke et al., 2002; L. Li et al., 1995; Oppenheim et al., 2000; Wood, 
Moore, et al., 2009; Yan, Matheson, & Lopez, 1995).  NGC’s delivering growth factors such as 
GDNF have been shown to shown to promote axonal regeneration better than isograft controls (Wood 
et al., 2010).  
Gradients of biological molecules are known to significantly affect nerve regeneration, as well 
as other biological processes such as, wound healing, embryogenesis, angiogenesis, and immunity (X. 
Cao & Shoichet, 2001; DeLong et al., 2005; Fisher et al., 1989; Kapur & Shoichet, 2004; K. Moore et 
al., 2006; Singh et al., 2008; X. Wang et al., 2009).  Our laboratory has created linear gradients in 
reversibly-bound GDNF within heparinated poly(ethylene glycol) (PEG) microsphere scaffolds 
(Roam et al., 2014, 2010).  These gradients persist for more than a week and might enhance nerve 
regeneration within an NGC.  However, before these microsphere scaffolds can be useful for in vivo 
nerve regeneration, several functionalities, including cell-initiated degradability, inter-microsphere 
cross-linking, and cell adhesion, must be incorporated into the microspheres.  
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Recent biomaterials approaches to tissue regeneration have sought to replicate the native 
degradability of natural biomaterials, such as fibrin, thereby stimulating the regeneration process 
(Ehrbar et al., 2007; M P Lutolf & Hubbell, 2005).  Peptide sequences sensitive to enzymatic 
cleavage have been integrated into hydrogels to this end.  Matrix metalloproteinase sensitive 
sequences have been used in a number of biomaterial systems (M P Lutolf et al., 2003; Matthias P 
Lutolf et al., 2003; Miller et al., 2010; Moon et al., 2010; Patterson & Hubbell, 2010; Raeber et al., 
2005; Seliktar, Zisch, Lutolf, Wrana, & Hubbell, 2004; West & Hubbell, 1999). Plasmin is a second 
enzyme that plays a key role in cell migration, especially during wound healing (West & Hubbell, 
1999). Plasmin sensitive sequences have also been used to extensively (Gobin & West, 2002; 
Halstenberg, Panitch, Rizzi, Hall, & Hubbell, 2002; Jo et al., 2010; Patterson & Hubbell, 2011; Van 
Dijk, Van Nostrum, Hennink, Rijkers, & Liskamp, 2010; West & Hubbell, 1999).  For this system, 
the sequence must not contain any internal lysines or cysteines in order to prevent unwanted 
crosslinking. The sequence GGVRNGGK is one previously used plasmin-degradable sequence that 
fits these constraints (Gobin & West, 2002).  This sequence, modified by adding a GC to N-terminus 
to make it reactive to vinyl-sulfone groups, could impart plasmin degradability to these PEG 
microspheres. 
To promote scaffold stability, it was necessary for the microspheres to cross-link to one 
another.  To accomplish this under physiological conditions without using agents that might interact 
with the GDNF, other ambient proteins, or the extending nerves themselves, we sought to utilize a 
Click reaction (Nwe & Brechbiel, 2009).  Click reactions are bioorthogonal reactions such as the 
Huisgen 1,3-dipolar cycloaddition between azides and alkynes, thiol-ene/yne photoadditions, and 
Staudinger ligation(Brummelhuis, Diehl, & Schlaad, 2008; Hoyle, Lowe, & Bowman, 2010; Iha et 
al., 2009; Nwe & Brechbiel, 2009; H. Y. Park, Kloxin, Scott, & Bowman, 2010).  Our lab has already 
utilized click reactions for both microsphere formation and inter-microsphere cross-linking for 
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scaffold stability (Nguyen et al., 2013).  Because copper, a common catalyst for these reactions, can 
be toxic to cells, we have focused on copper-free azide–alkyne cycloadditions, which have high 
conversions, fast kinetics, insensitivity to oxygen and water, stereospecificity, regiospecificity, and 
mild reaction conditions (Clark & Kiser, 2009; DeForest, Polizzotti, & Anseth, 2009; Deforest et al., 
2010; Johnson, Baskin, Bertozzi, Koberstein, & Turro, 2008).  
To allow extending nerves to attach to and subsequently grow through the scaffold, it was 
necessary to affix a cell adhesion protein, such as laminin, to the microspheres.  Laminin, a basement 
membrane protein, has been shown to be important to neural system development (Swindle-Reilly et 
al., 2012). Laminin not only influences cell adhesion,  but also neurite outgrowth and growth cone 
movement, and acts as a neuronal cue (Culley et al., 2001; Evans et al., 2007; Swindle-Reilly et al., 
2012).  Many studies have already utilized laminin in their biomaterial systems to enhance neurite 
outgrowth (Dodla & Bellamkonda, 2008; Jurga et al., 2011; Neal et al., 2012; Swindle-Reilly et al., 
2012; X Yu et al., 1999; Xiaojun Yu, Dillon, Bellamkonda, & Ph, 1999).  The cell adhesion 
molecules fibronectin and an RGD peptide have previously been attached to the PEG microspheres 
via reaction of cysteines in the molecule with vinyl-sulfone groups on the PEG, and the same 
chemistry was used for conjugating laminin to the microspheres herein (E. a. Scott et al., 2010). 
This study seeks to combine these various functionalities into these gradient-producing PEG 
microsphere scaffolds for use in NGC’s.  As an important step towards testing this system in vivo, 
NGC’s containing these scaffolds were implanted into rats, traversing a severed sciatic nerve, to 
assess the degradability as well as any safety issues.  
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4.3 Materials and Methods 
Unless otherwise noted, all reagents were purchased from Sigma–Aldrich. 
4.3.1 PEG Synthesis  
PEG8-vinylsulfone (PEG8-VS) and PEG8-amine were synthesized from eight-arm PEG-OH 
(PEG8-OH; mol. Wt. 10,000; Shearwater Polymers, Huntsville, AL) as previously described (Wacker 
et al., 2006).  PEG macromonomers were dissolved separately at 200 mg/mL in Dulbecco’s 
phosphate buffered saline (PBS; 8 mM sodium phosphate, 2 mM potassium phosphate, 140 mM 
sodium chloride, 10 mM potassium chloride, pH 7.4) and sterile filtered with 0.22 μm syringe filters 
(Millipore).    
4.3.2 Heparin Attachment Pre-Microsphere Formation (for high 
heparin microspheres) 
A solution 244 mg/mL Heparin sodium salt (mol. wt. ~18,000, ~2.78 mM), 0.081 mM N-(3-
Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), and 0.203 mM N-Hydroxy-
succinimide (NHS) in MES buffer (10 mM, pH 6.0) was incubated at room temperature for 30 min.  
L-Cysteine (free base) was added to the activated heparin solution to make a 6:1 cysteine:heparin 
molar ratio and allowed to react overnight.  The solution was dialyzed in 10X PBS (pH 7.4) to 
remove unreacted cysteine.   Ellman’s assays were performed to determine substitution of cysteine on 
heparin (44% of heparin molecules determined to have cysteine).  PEG8-VS was added at a 10:3 
PEG8-VS:cysteinated-heparin molar ratio and incubated at room temperature overnight.  For 
microsphere formation, heparin-conjugated PEG8-VS was mixed with PEG8-amine in a 1:1 ratio of 
the two PEG types (see Figure 4.1A). 
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4.3.3 Ellman’s Assay 
Ellman’s reagent was dissolved in 0.1 M phosphate buffer (pH 8.0) at 40 mg/mL. 0.05-0.15 
μmol of cysteinated heparin was added to 3 mL of 0.1 M phosphate buffer (pH 8.0) along with  100 
μL Ellman’s solution. The solution was mixed and incubated at room temperature for 15 minutes.  
Absorbance at 412nm was measured and compared to standard to determine cysteine content.  
4.3.4 High Heparin Microsphere Formation 
Heparinated PEG8-VS solutions were combined with PEG8-amine solutions at a 1:1 ratio. The 
PEG solutions were diluted to 20 mg/mL PEG with PBS and 1.5 M sodium sulfate (in PBS) to a final 
sodium sulfate concentration of 0.6 M.  The PEG8-VS/PEG8-amine solutions were then incubated 
above the cloud point at 70˚C for 11 minutes.  Suspensions of microspheres were subsequently buffer 
exchanged into 8 mM sodium phosphate twice to remove the sodium sulfate by: (1) diluting the 
microsphere solution 3:1 with PBS and titurating, (2) centrifuging at 14,100g for 2 min, and (3) 
removing the supernatant. Fluorescent and phase contrast images were captured using a MICROfire 
(Olympus, Center Valley, PA) camera attached to an Olympus IX70 inverted microscope.  
4.3.5 Heparin Attachment Post-Microsphere Formation 
A solution of 515 mg/mL Heparin sodium salt (mol. wt. ~18,000, ~2.78 mM), 0.101 mM N-
(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), and 0.042 mM N-Hydroxy-
succinimide (NHS) in MES buffer (10 mM, pH 6.0) was incubated at room temperature for 30 min.  
L-Cysteine (free base) was added to the activated heparin solution to make a 8.82:1 cysteine:heparin 
molar ratio and allowed to react overnight.  The solution was dialyzed in 10X PBS (pH 7.4) to 
remove unreacted cysteine.   Ellman’s assays were performed to determine substitution of cysteine on 
heparin (109% of heparin molecules determined to have cysteine).  The solution was diluted to 130 
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mg/ml heparin and stored at -20˚C.  For heparination of microspheres, cysteine-conjugated heparin 
was added to PEG microspheres at 2.6 mg/mL and incubated overnight (see Figure 4.1B).  
 
4.3.6 Heparin Labeling 
To confirm post-microsphere formation attachment, cysteinated heparin was labeled with 
Dylight-488 NHS-ester (Pierce).  Cysteinated heparin (130 mg/mL) and Dylight-488 (560 g/mL) in 
 
Figure 4.1. Heparin Addition Chemistry.  A. Heparin addition chemistry for high heparin microspheres 
utilizing a “thiolated heparin” intermediate (maximum microsphere heparin content, 21% by weight).  B. Post-
microsphere formation heparin addition chemistry (maximum microsphere heparin content, 4% by weight).   
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PBS was incubated overnight at room temperature.  The labeled heparin solution was dialyzed using 
Slide-A-Lyzer MINI Dialysis Units (Thermo Scientific, Rockford, IL, 3500 MWCO) in PBS (pH 7.4) 
to remove any unbound Dylight-488.  The heparin solution was then used in the heparination post-
microsphere formation protocol as described above.  Fluorescence of suspended microsphere solution 
was measured and compared to a standard curve to determine heparin content (3.97% heparin by 
weight).  
4.3.7 Plasmin-Degradable PEG Synthesis 
Peptide sequence GCGGVRNGGK (N-Terminal Acetylation, C-Terminal Amidation, Purity 
>95%, GenScript USA Inc., Piscataway, NJ) was dissolved in 0.1 M phosphate buffer  at 117.9 
mg/mL with PEG8-VS (200 mg/mL, 78% substitution) and brought to a pH of 7.4. The solution was 
incubated overnight at room temperature before storage at 4˚C.  
4.3.8 Plasmin-Degradable Microsphere Formation 
PEG8-VS solutions were combined with degradable PEG8-VS (PEG-(VRN)8) solutions at a 1:1 molar 
ratio and incubated at 37˚C for 1 hour. The PEG solutions were diluted to 20 mg/mL PEG with PBS 
and 1.5 M sodium sulfate (in PBS) to a final sodium sulfate concentration of 0.6 M.  PEG8-
Azide/Amine or PEG8-CO/Amine were added to the regular PEG solutions at a 50:1 PEG8-VS/PEG-
(VRN)8 to Clickable PEG ratio. The PEG8-VS/PEG-(VRN)8 solutions were then incubated above the 
cloud point at 70˚C for various times.  Suspensions of microspheres were subsequently buffer 
exchanged into 8 mM sodium phosphate twice to remove the sodium sulfate by: (1) diluting the 
microsphere solution 3:1 with PBS and titurating, (2) centrifuging at 14,100g for 2 min, and (3) 
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removing the supernatant (see Figure 4.2). 
 
4.3.9 PEG8-Azide/Amine Synthesis 
 Eight arm PEG-mesylate (PEG8-mesylate; mol wt 10,000) was first synthesized from 
four arm PEG-OH (PEG8-OH; mol wt 10,000; Creative PEGWorks) by mesylating the alcohol group 
on PEG8-OH with mesyl chloride. This was done by dissolving PEG8-OH in dichloromethane 
(DCM), adding four equivalents of triethylamine and four equivalents of methanesulfonyl chloride 
while on ice, and letting it react overnight under constant stirring and nitrogen flow. After removing 
the salt byproduct, excess DCM was removed by using the rotovap, and the PEG8-mesylate was 
precipitated out using cold diethyl ether. The product was dried under vacuum overnight to remove 
 
Figure 4.2. Addition of Plasmin Degradability to Microspheres.   
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any remaining diethyl ether. The next step was the nucleophilic azidation of the mesylate group with 
sodium azide. Three equivalents of sodium azide were dissolved in dimethylformamide (DMF). 
PEG8-mesylate was then dissolved in the DMF mixture and put under nitrogen and constant stirring 
in a hot water bath at 60°C. The reaction was run overnight. The following day required the filtration 
of excess salt followed by rotovapping, diethyl ether precipitation, and drying as was done for the 
PEG8-mesylate. The product was dissolved in a basic water solution with a pH between 9 and 12, and 
then extracted with DCM over anhydrous sodium sulfate (Na2SO4). A standard extraction procedure 
was done to extract the product into DCM. After three extractions, the Na2SO4 was filtered out and 
the process of rotovapping, diethyl ether precipitation, and drying was done as before. 1H NMR (300 
MHz, CDCl3, δ): (s, 902.55H, PEG), 3.0 (s, 3H, -SO2CH3), 4.3 (t, 2H, -CH2OSO2-). NMR of the 
product confirmed that no mesylate features remained at 3.0 ppm and 4.3 ppm. 
PEG8-azide was dissolved in tetrahydrofuran (THF) and 1.15 equivalents of 
triphenylphosphine (TPP) and 30 equivalents of ultrapure H2O were added while on ice, and the 
reaction was allowed to go overnight under constant stirring and nitrogen flow. A large excess of 
H2O to TPP was needed for amine formation. Excess THF and H2O were removed by rotovapping, 
and PEG8-Azide/Amine and triphenylphosphine oxide (TPPO) were precipitated out using cold 
diethyl ether. The product and byproduct were dried under vacuum overnight to remove any 
remaining diethyl ether. Once dry, the PEG8-Azide/Amine and TPPO have cold toluene added, since 
TPPO is soluble in cold toluene and PEG is insoluble. The PEG8-Azide/Amine was then vacuum 
filtered to remove the TPPO. The product then underwent the same extraction procedure with DCM 
that was done in the PEG8-Azide synthesis. 1H NMR (300 MHz, CDCl3, δ): (s, 902.55H, PEG), 2.9 
(t, 2H, -CH2CH2NH2). NMR of the product confirmed the reduction of 50 percent of azides to 
amines with the amine feature at 2.9 ppm. 
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4.3.10 PEG8-CO/Amine Synthesis 
Amines on PEG8-Amine (prepared as previously described) were partially converted to  
cyclooctynes to form PEG8-CO/Amine. PEG8-Amine was dissolved in DCM in a beaker, and 0.5 
equivalents of diisopropylcarbodiimide (DIPCDI) were added to a separate spherical flask with DCM 
while on ice and under nitrogen flow and constant stirring. Next, 0.5 equivalents of 
hydroxybenzotriazole (HOBt) and 0.5 equivalents of aza-dibenzocyclooctyne with a pendant 
carboxylic acid (DBCO-acid; Click Chemistry Tools) were added to the mixture in the flask and 
allowed to stir for 10 minutes. While waiting, one equivalent of N,N-diisopropylethylamine (DIPEA) 
was added to the dissolved PEG8-Amine. Finally, this mixture was slowly added to the spherical 
flask, and the reaction was allowed to go for 24 hours in the ice bath, under constant stirring and 
nitrogen gas. Following that process, the urea precipitate was filtered out, and rotovapping, diethyl 
ether precipitation, and drying was performed. The product was then dissolved in distilled H2O and 
underwent the same extraction procedure that was done for the PEG8-Amine. Further rotovapping, 
diethyl ether precipitation, and drying were done. 1H NMR (300 MHz, CDCl3, δ): (s, 902.55H, 
PEG), 5.1 (d, 2H, -CH2-). NMR of the product confirmed the conversion of 50 percent of amines to 
cyclooctynes (PEG8-CO/Amine) with the presence of a doublet at 5.1 ppm. 
4.3.11 Clickable Microsphere Formation 
PEG8- Azide/Amine and PEG8-CO/Amine were separately dissolved in 0.1 M phosphate 
buffer (pH 7.4) at 40 mg/mL. Dylight-633 NHS-ester (Pierce) was dissolved in dimethyl formamide 
at 10 mg/mL and added to the clickable PEG’s such that final concentrations were 33.33 mg/mL 
clickable PEG and 1.67 mg/mL Dylight. Solutions were incubated overnight at 25˚C to allow near 
complete reaction. The same methods for degradable microsphere formation were followed, except 
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that just prior to dilution in 0.6 M sodium sulfate, PEG8-Azide/Amine and PEG8-CO/Amine were 
added to separate batches of the degradable microsphere precursor solution at a 1:50 clickable PEG to 
other PEG molar ratio.  The methods for degradable microsphere formation continued to be followed 
from this point, making sure to keep batches containing PEG8-Azide/Amine and PEG8-CO/Amine 
separate until just prior to scaffold formation. (see Figure 4.4) 
4.3.12 Laminin Attachment 
Laminin Mouse Protein, Natural (Life Technologies, Grand Island, NY) was added to 
microspheres at 20 μg/mL or 2-D gel 0.8 μg/mL and incubated at 37˚C overnight. 
4.3.13 Cysteine capping of Vinyl-Sulfones 
After all other functionalities were added to the microspheres (the last step being incubation 
with thiolated heparin and laminin) the microspheres were washed 2X and resupended in 2.5 mg/mL 
L-cysteine and incubated for 30 minutes at room temperature.  The microspheres were then washed 
3X before use.  
4.3.14 GDNF Loading of Microspheres 
Recombinant human GDNF (Peprotech, Rocky Hill, NJ) was dissolved in 8 mM sodium 
phosphate buffer (pH 7.4) and added to washed microspheres such that the GDNF concentration 
within the supernatant was 250 ng/mL (higher concentrations used for DRG experiments).  The 
microsphere/GDNF solution was well mixed, by tituration and incubated 2 hours at 4˚C to allow 
diffusion of the GDNF into the microspheres.  Immediately before scaffold formation, the 
microspheres were centrifuged at 14,100 g, supernatant was removed, and microspheres were 
resuspended in 8 mM sodium phosphate.  
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4.3.15 GDNF  Labeling 
Dylight-488 NHS-ester (Pierce) was dissolved in dimethyl formamide at 10 mg/mL.  
Recombinant human GDNF (Peprotech, Rocky Hill, NJ) was dissolved in 8 mM sodium phosphate 
buffer (pH 7.4).  Dylight-488 was added to the solution for a final GDNF concentration of 10 μg/mL 
and a final Dylight-488  concentration of 50 ng/mL and incubated overnight at 2˚C.  The solution was 
then dialyzed using Slide-A-Lyzer MINI Dialysis Units (Thermo Scientific, Rockford, IL, 3500 
MWCO) in 8 mM sodium phosphate buffer (pH 7.4) to remove unbound Dylight-488. 
4.3.16 Confirmation of Gradient Formation 
The glass walls of Pasteur pipettes were passivated with PLL(375)-g[7]-PEG(5) (D. L. Elbert 
& Hubbell, 1998; Kenausis et al., 2000).
 
 The pipettes were filled with a 20 mg/mL PLL-g-PEG 
solution, incubated for 30 seconds, and washed with DI water.  After sufficient drying time, the tips 
of the pipettes were sealed with silicone aquarium sealant (DAP Inc., Baltimore, MD).  To form 
scaffolds, microsphere solutions loaded or unloaded with labeled GDNF were sequentially added to 
the pipettes that were placed in 15 mL conical vials.  The microsphere solutions were centrifuged at 
1000 g for 5 min before the next layer of microspheres (not loaded with GDNF) was added.  The 
supernatant was then removed once more and replaced with 8 mM Sodium Phosphate. 
4.3.17 Confocal microscopy 
Fluorescence microscopy was performed with a Nikon Eclipse C1/80i confocal microscope.  
Microsphere gradients were imaged while still in the Pasteur pipettes with a 10X objective (NA=0.30, 
DIC L/N1, WD= 16.0mm).  Multiple images were taken along the length of the pipette and processed 
using EZ-C1 3.70 FreeViewer software (Nikon Instruments Inc.) and then combined.  Fluorescence in 
the composite photographs was analyzed with ImageJ software.  
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4.3.18 Analysis of GDNF Activity Retention 
PEG8-VS and PEG8-Amine solutions were combined at a 1:1 ratio and diluted to 66.66 
mg/mL PEG in PBS.  0.6 mL of the PEG solution was added to each well of a 24 well plate (BD 
Falcon, Franklin Lakes, NJ) and incubated at 37˚C for 3 days. Wells were washed 2X with 1 mL PBS 
before adding 0.6 mL of Laminin (0.8 μg/mL) in PBS and incubated at 37˚C overnight.  GDNF (833 
ng/mL 8 mM sodium phosphate buffer) was loaded into microspheres as decribed above.  After 
incubation, microspheres were centrifuged and supernatant was removed.  Microspheres were 
resuspended in modified neurobasal (MNB) media (Invitrogen, Carlsbad, CA) containing 0.1% BSA, 
0.5 mMl-glutamine, 2.5 μMl-glutamate, 1% N2 supplement, and 1% antibiotic/antimycotic solution 
(ABAM) (all from Invitrogen) and quickly centrifuged again to remove free GDNF.  Supernatant was 
removed and the microspheres were resuspended in MNB media (1 mL of media for about 0.5 mL of 
loaded microspheres) and incubated 2 hours at 4˚C.  The microspheres were centrifuged once again 
and the supernatant was transferred to the 24 well plate with PEG gels (1 mL per well).  Dorsal root 
ganglions (DRGs) were dissected from day 10 White Leghorn chicken embryos (Sunrise Farms, 
Catskill, NY) and placed into wells containing either microsphere MNB media or fresh MNB media 
(no GDNF). At 24, 48, and 72 hours, phase contrast images of the neurite extension from the DRGs 
were taken with the 4x objective. 
4.3.19 Conduit Assembly 
Sections of standard silicone tubing (Helix Medical, Carpinteria, CA) (1.47 mm inside diameter × 
0.39 mm wall thickness) were stretched over the ends of a 1mL pipette tips (Rainin Instrument LLC, 
Oakland, CA) until secure with ~2 cm protruding from the ends.  After autoclaving, a small amount 
(~3mm once inside tube) of hot glue was drawn into the tube to form a plug.  Plugged tips were 
stored under UV to enhance sterility in a sterile cabinet. Fibrinogen solutions were prepared by 
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dissolving human plasminogen-free fibrinogen in deionized water at 8 mg/mL for 1 h and dialyzing 
vs. 4 L of Tris-buffered saline (TBS) (33 mM Tris, 8 g/L NaCl, 0.2 g/L KCl) at pH 7.4 overnight to 
exchange salts present in the protein solution. The resulting solution was sterilized by filtration 
through 5.0 and 0.22 μm syringe filters, and the final fibrinogen concentration was determined by 
measuring absorbance at 280 nm.  Components were mixed to obtain the following final solution 
concentrations: 8 mg/mL fibrinogen, 2.5 mM Ca2+, and 1 NIH U/mL of thrombin.  Using a 30 gauge 
syringe (Exel International Medical Products, St. Petersburg, FL), this solution was added inside the 
tube on top of the glue plug such that a 1-2 mm plug of fibrin was formed. The conduits were then 
incubated for 1 hour at 37˚C. The pipette tip and conduit were them placed inside a 3-D printed mold 
designed to allow for centrifugation of the conduit (Figure 4.12).  Microspheres were then added to 
the pipette tip and centrifuged to form a scaffold within the tube as previously described.  The conduit 
was then cut away from the tip.  The supernatant was removed from the microspheres, and another 
small fibrin plug was added on top of the microspheres.  The glue plug was then excised by cutting 
the silicone tube around the plug 1 mm from the top of the plug and pulling the plug free (Figure 4.12 
A and B). 
4.3.20 Experimental Animals 
 Adult male Lewis rats (Charles River Laboratories, Wilmington, MA), each weighing 250–
300 g, were used in this study. All surgical procedures and perioperative care was performed in 
accordance with the National Institutes of Health guidelines, where NIH guidelines (or for non-U.S. 
residents similar national regulations) for the care and use of laboratory animals (NIH Publication 
#85-23 Rev. 1985) have been observed. 
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4.3.21 Operative Procedure 
All surgical procedures were performed using aseptic technique and microsurgical dissection 
and repairs. Under subcutaneous anesthesia with ketamine (75 mg kg−1) and medetomidine (0.5 mg 
kg−1), the hind leg of the rat was prepped with betadine and alcohol and the sciatic nerve was 
exposed through a dorsolateral gluteal muscle splitting incision. A 5 mm nerve segment was excised 
proximal to the trifurcation of the sciatic nerve and a nerve guidance conduit was sutured to the 
transected proximal and distal stumps, incorporating 1 mm of nerve on either end. Two 9-0 nylon 
interrupted microepineurial sutures were used to secure the conduit at each end, resulting in a 13mm, 
tension-free gap between the proximal and distal stumps. Wounds were irrigated with saline, dried 
and closed with a running 5-0 vicryl suture in muscle fascia, and then interrupted 4-0 nylon skin 
sutures. 
Anesthesia in experimental animals was then reversed with a subcutaneous injection of 
atipamezole HCl (1 mg kg−1) (Pfizer Animal Health, Exton, PA), and the animals recovered in a 
warm environment. After recovery, the animals were returned to the housing facility. 
At 1, 2, 4, 6, and 8 weeks postoperatively, all animals were re-anesthetized and the 
conduits/nerves were exposed by reopening the prior muscle splitting incision.  At this time, light and 
fluorescence photomicrographs were taken, and the wounds were re-closed as before. At 8 weeks, the 
nerve conduit and a 5 mm portion of native nerve both proximally and distally were harvested. The 
specimens were marked with a proximal suture and stored in 3% glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.2) at 4 °C until immunohistochemical analysis was performed (Hunter et al., 2007).  
Following the tissue harvest, the animals were then euthanized with intraperitoneal injection of 
Euthasol (150 mg kg−1) (Delmarva Laboratories, Des Moines, IA). 
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4.3.22 Immunohistochemistry 
Cross-sections of the delivery system and nerve were cut at 10 µm on a cryostat and stained 
with S100: 1:500, rabbit anti S100 (Dako) primary antibody followed by S100: goat anti rabbit 555 
secondary antibody and NF-160 mouse polyclonal primary antibody followed by NF-160: 488 goat 
anti mouse secondary antibody using standard immunohistochemistry techniques. 
 
4.4 Results and Discussion 
4.4.1 New Heparin Binding Strategies 
 For this system we devised a new heparin attachment chemistry that would alleviate limits 
(controllability, maximum amount of heparin) of the previous method of incorporating heparin into 
the microspheres.  In this new chemistry, seen in Figure 4.1A, an intermediate step of bonding 
cysteine to the heparin through a previously used EDC/NHS activation of carboxyl groups was added 
to the previous method (Roam et al., 2014).  The amount of cysteine conjugated to the heparin was 
evaluated by an Elman’s assay for the thiols on the cysteines. This “thiolated heparin” could then be 
reacted with PEG8-VS in a much more controlled manner than the previous reaction of activated 
carboxyl groups with PEG8-Amine.  This allowed for the creation of microspheres with as much as 21 
percent by weight heparin content.  However, these higher amounts of heparin inhibited, and 
sometimes even prevented, the formation of microspheres.  Microspheres that were successfully 
formed in these high heparin conditions were much smaller (less than 1 micron in diameter, Figure 
4.3) than the previously fabricated microspheres (5-20 microns).  Upon introduction of further 
functionalities such as plasmin degradability, microspheres no longer formed at all unless the heparin 
content was dropped to levels below that which the previous chemistry afforded (less than 3 percent 
by weight).  Thus, we altered this method, creating the thiolated heparin as before, but only bonding 
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the thiolated heparin to PEG8-VS after the microspheres had been formed (see Figure 4.1B).  To 
assess the heparin content of these microspheres, we labeled the heparin with Dylight-488.  By 
comparing the fluorescence of a solution of suspended heparinated microspheres to standard curve of 
fluorescent thiolated heparin, the heparin content of the microspheres was determined to be at least 4 
percent by weight.  This heparin content was greater than the previous system yielded, while having 
the added benefit of not interfering with the microsphere formation process.  
4.4.2 Addition of Degradable Peptide 
 To allow nerves extending axons to degrade the scaffold as they move through, a plasmin 
sensitive peptide sequence, GCGGVRNGGK, was incorporated into the microspheres (see Figure 
4.2). The cysteine contains a thiol group that will react quickly with vinyl sulfone groups on the 
PEG8-VS.  By combining the peptide with PEG8-VS such that there was one peptide chain for every 
vinyl sulfone group and giving ample time for complete reaction (overnight, room temperature), we 
created an eight arm PEG with arms vulnerable to attack by plasmin.  We refer to this as PEG-
(VRN)8. The lysine the C-terminal end of the peptide causes each arm to end in an amine group, 
effectively producing a plasmin-degradable PEG8-Amine.  Regular PEG8-Amine could now be 
substituted with this PEG-(VRN)8 in the microsphere formation process.  The N-terminus and C-
terminus of the peptide were acetylated and amidated, respectively, to prevent any unwanted cross-
linking during microsphere formation.  To form microspheres, PEG-(VRN)8 and PEG8-VS was added 
at a 1:1 molar ratio and reacted as the previous PEG8-Amine/ PEG8-VS constituents were.  The 
production of microspheres was hindered somewhat by the introduction of the PEG-(VRN)8, 
however, due possibly to electrostatic interactions of the peptide.  In order for microspheres to form, a 
pre-incubation step had to be added, in which the undiluted PEG-(VRN)8/PEG8-VS mixture (200 
mg/mL PEG) was incubated for at least 30 minutes (1 hour in final protocol) at 37˚C before dilution 
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in 0.6 M sodium sulfate and subsequent incubation at 70˚C.  All cross-linkages between PEG 
molecules in the microspheres that were formed were vulnerable to attack by plasmin. 
 
4.4.3 Addition of Click Crosslink 
PEG microspheres with click cross-linking functionality have already been developed by our 
laboratory (Nguyen et al., 2013).  PEG8-Amine fifty percent substituted with either azide or 
cyclooctyne groups (PEG8-Azide/Amine and PEG8-CO/Amine) was added to the microspheres 
during formation producing batches of microspheres decorated with either azide or cyclooctyne 
groups. Upon the mixing of these two types of microspheres together, the click agents reacted to one 
another, covalently coupling the microspheres together into a scaffold (see Figure 4.4).  However, 
with the addition of the clickable PEG agents (more specifically, the non-degradable PEG-Amine 
arms within the clickable PEG agents), the individual microspheres became so thoroughly cross-
linked that they lost their ability to be degraded. By lowering the amount of clickable-PEG added to 
the microspheres we were able to recover plasmin degradability, but only once the clickable PEG 
content was lowered to a 50:1 non-clickable PEG:clickable PEG molar ratio.  At this level, enhanced 
 
Figure 4.3. High Heparin Microspheres.  A. Phase-contrast image of high heparin microspheres (400X). B. 
Flourescent image of Dylight-488 Labeled heparin in high heparin micropheres (400X). 
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scaffold stability due to click cross-linking was not observed until after the scaffold had sat for a 
considerable amount of time (more than a few days).  When implanted in vivo these scaffold will be 
in place for weeks, so the click cross-linking functionality will still be advantageous for the system.
  
 
4.4.4 Addition of Laminin 
The final functionality added to the microspheres was cell adhesion, via laminin.  To confirm 
laminin would encourage neuronal growth on the microspheres, 2D gels made from PEG8-Amine/ 
PEG8-VS (6.66% in PBS) were incubated overnight with laminin (20 μg/mL) at 37˚C, allowing the 
cysteines on laminin to react with free vinyl-sulfones, covalently coupling the laminin to the gels.  
DRG’s were cultured on the gels with laminin and compared to those without (Figure 4.5).  DRG’s 
cultured on PEG gels without laminin showed no growth at all.  DRG’s cultured on PEG gels with 
laminin extended neurites.  This confirmed that laminin did attach to the gel and subsequently 
encouraged neurite growth.  To attach laminin to the microspheres, laminin (20 μg/mL) was added to 
 
Figure 4.4. Scaffold formation by Click Cross-Linking. PEG8-Azide/Amine and PEG8-CO/Amine were 
added to the microspheres during formation producing batches of microspheres decorated with either azide or 
cyclooctyne groups.  Upon mixing and centrifugation, the click agents will react to one another, covalently 
coupling the microspheres into a scaffold. 
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previously formed and washed microspheres and incubated overnight at room temperature. 
 
4.4.5 Combining Functionalities 
Once the addition of each functionality (heparin binding, plasmin degradability, click cross-
linking, and cell adhesion) was demonstrated, they needed to be combined into one material.  The 
final method for fabricating these fully functionalized microspheres is shown in Figure 4.6.  This 
protocol is the combination of all the processes discussed above ending in a 30 minute incubation in 
2.5 mg/mL cysteine to cap any remaining free vinyl-sulfone groups.  This prevented any unwanted 
 
Figure 4.5. Laminin Promoted Growth of DRG’s.  A. Sample DRG growth  on PEG8-VS/PEG8-Amine gels 
decorated with Laminin at 20 μg/mL. (2 days after seeding, dashes show border of growth). B. DRG growth  on 
PEG8-VS/PEG8-Amine gel without Laminin. (2 days after seeding, dashes show border of growth).  C. Average 
neurite extension in mm for DRG’s cultured on PEG gel with and without laminin (n=5). No growth was 
observed in DRG’s without Laminin present. Error bars shown but equal to 0 for the –Laminin condition. 
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covalent binding of the microspheres to GDNF (or any other proteins) as demonstrated in our 
previous work (Roam et al., 2014).  
 
 While the lowered amount of click agents (50:1 Non-clickable PEG to clickable PEG) allowed 
for the retention of plasmin degradability, this is only with a particular range of microsphere 
formation incubation times.  For less than 8 minutes at 70˚C, no microspheres formed.  For more than 
10 minutes, the microspheres cross-linked to a degree that eliminated their ability to be degraded by 
plasmin.  Within this range, 8-10 minutes incubation at 70˚C, the rate of degradation was tunable.  To 
 
Figure 4.6. Final Functionalized Microsphere Procedure.  A. PEG-(VRN)8 and PEG8-VS (200 mg/mL) 
were combined at 1:1 molar ratio and incubated at 37˚C for 1 hour.  B. PEG8-Azide/Amine and PEG8-
CO/Amine were added at 1:50 (Click:Regular) ratio. C. PEG was diluted to 20 mg/mL in 0.6 M Na2SO4 and 
incubated 8 min at 70˚C. D. Microspheres were washed 3X in PBS and Thiolated Heparin (2.6 mg/mL) and 
Laminin (20 μg/mL) was added to suspended μspheres and incubated at 25˚C overnight. Microspheres were 
washed 2X in low salt buffer. E. Cysteine (2.5 mg/mL) was added and incubated 25˚C for 30 minutes to cap 
remaining vinyl-sulfones. Microspheres were washed 2X in low salt buffer.  F. The two microsphere types 
were combined prior to growth factor loading and/or scaffold formation. 
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test the rate of degradability, microspheres were suspended in 1 unit/mL of plasmin and incubated at 
37˚C, with samples taken periodically to be viewed by phase-contrast microscopy.  Microspheres 
incubated less than 10 minutes degraded in a matter of hours while 10 minute incubated microspheres 
degraded over the course of days or not at all. A graph and representative samples of this process are 
shown in Figure 4.7.  Those microspheres with above a 10 minute incubation time did not degrade 
completely and are not shown.  In this experiment, each of the suspended microspheres was attacked 
from all directions by the plasmin in which they were suspended.  In vivo, however, nerves releasing 
plasmin must eat away at the microsphere scaffold from one direction, which will take a considerably 
greater amount of time.  Thus, this should represent an accelerated model compared to in vivo. 
 
With the protocol for the fabrication of these microspheres finalized, we needed to confirm 
that the linear concentration gradient making capability discussed in the previous study was retained 
(Roam et al., 2014).  A two-tier initial step gradient in GDNF was created as before, using these fully 
 
Figure 4.7. Degradation of Microspheres Suspended in Plasmin.  Microspheres formed by incubation at 
70˚C for 8 and 9 minutes were suspended in 1 unit/mL of plasmin and incubated at 37˚C to view the rate of 
degradation.  Graph shows average microsphere diameter over time for 8 (blue), 9 (red), and 10 minute (green) 
formation times.  Yellow dashes indicate 9 minute microspheres in control conditions (no plasmin). (n=4) 
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functionalized microspheres. The release profile of the GDNF visualized by confocal microscopy is 
shown in Figure 4.8.  The initial step gradient formed a very linear shape after one day.  This shows 
that the fully functionalized microspheres form linear concentration gradients in GDNF just as the 
previous microspheres did.  
 
4.4.6 Confirmation of GDNF Activity Retention 
The next important question to answer was whether or not GDNF loaded into the 
microspheres and subsequently released retains its biological activity.  DRG’s cultured on 2D PEG8-
Amine/ PEG8-VS with laminin extended neurites regardless of inclusion of GDNF (100 ng/mL) in the 
media.  Differences between DRG’s given media with and without GDNF were only observed once 
the concentration of laminin incubated on the gel was drastically decreased.  It was only within a 
range of 0.5-1.0 μg/mL laminin incubated on the PEG gel that a difference was observed.  DRG’s in 
both conditions (with and without GDNF) extended neurites on these gels initially.  However, after 2-
 
Figure 4.8. Confirmation of GDNF Gradients. 2-tier initial profile, “low salt” (8 mM sodium phosphate) 
release of Dylight-488 labeled GDNF from fully functionalized microsphere scaffold. (A) Composite 
photograph of fluorescence (GDNF) in scaffold at the zero time point, one day, and 5 days. (B) Graphical 
depiction of fluorescence (GDNF concentration) vs. the distance in the scaffold for the four time points: zero 
(blue), 1 day (green), and 5 days (red). n=4 sample error bars shown. 
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3 days (length of time varied between experimental sets) there would come a point when DRG’s 
without GDNF would lose their extensions or even detach from the gel completely while the DRG’s 
given GDNF (100 ng/mL) in the media would stay attached and healthy looking.  With this 
knowledge, an experiment was performed comparing the growth of DRG’s given media without 
GDNF to those given media with GDNF released from the fully functionalized microspheres.   
 Fully functionalized microspheres were fabricated and washed thoroughly.  Enough 
microspheres were made such that there would be approximately 0.5 mL of microspheres for every 1 
mL of cell culture media needed.  The microspheres were then suspended in low salt buffer (8 mM 
sodium phosphate, pH 7.4) with a high concentration of GDNF (833 ng/mL for the experiment shown 
in Figures 4.9 and 4.10) and incubated for 2 hours at 4˚C to give the GDNF plenty of time to 
thoroughly infiltrate the microspheres.  The microspheres were then centrifuged and the supernatant 
was removed.  The microspheres were next loaded with GDNF.  However, some GDNF that had not 
interacted with the microspheres could be in the media between microspheres.  To remove this GDNF 
as well as avoid dilution of the cell culture media, the microspheres were resuspended in MNB media 
and quickly (less than 10 seconds later) centrifuged again.  The supernatant was removed and the 
microspheres were once again resuspended in fresh MNB media.  The suspended microspheres were 
incubated for 2 hours at 4˚C to thoroughly release the loaded GDNF into the MNB media.  The 
microspheres were then centrifuged and the supernatant (MNB media with released GDNF, no 
microspheres) was transferred to a 24 well plate containing the PEG gel (with 0.8 μg/mL incubated 
laminin) and DRG’s.  Phase-contrast photo micrographs were taken at 1, 2, and 3 days.  The results 
are shown in Figures 4.9 and 4.10. In Figure 4.9, examples of DRG’s cultured with microsphere 
released GDNF and without GDNF are shown.  At day 3, DRG’s without GDNF have lost their 
extensions and detached from the gel completely while the DRG’s given GDNF from microspheres 
stayed attached and healthy looking. In fact, all DRG’s not given GDNF had no extensions at this 
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time point.  Figure 4.10 shows the average neurite extension of the two conditions. The conditions 
look similar for the first two days, but at day 3, the average extension of the DRG’s given 
microsphere released GDNF was maintained from day 2 while the average extension of the DRG’s 
without GDNF falls to zero.  This drastic difference in the two cases shows that the GDNF loaded 
into and subsequently released from the microspheres retains its biological activity. 
 
 
Figure 4.9. GNDF Activity Retention - DRG growth. DRG growth on PEG gels with 0.8 μg/mL incubated  
laminin for one, two, and three days under two media conditions:  A. Microsphere released GDNF (833 ng/mL 
incubation) in MNB media,  B. MNB media with no GDNF. Yellow dashes indicate boundary of neurite 
extension. 
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4.4.7 Conduit Formation and In Vivo Testing 
 Lastly we transferred our gradient containing scaffolds made up of fully functionalized 
microspheres to NGC’s. Microspheres, incubated for various times to alter the degradation rate, were 
centrifuged into silicone tubes by stretching the tube securely over a 1 mL pipette tip and stopping up 
the end with hot glue (Figure 4.11A).   This was enclosed within a custom made 3D printed mold, 
which could be inserted into a 15 mL conical vial for centrifugation (Figure 4.11 B-D). The NGC was 
then excised from the pipette tip, and the glue plug was removed (4.12 A and B). Though handling 
and implantation of the conduits was possible, it was also difficult, and the scaffold within was easily 
destabilized. Fibrin plugs were formed at either end of the scaffold to increase stabilization (fibrin 
plugs can be seen in Figure 4.12 A and B).  Conduits were then ready for in vivo testing. 
 
Figure 4.10. GNDF Activity Retention – Neurite extension analysis. Average neurite extension for DRG’s 
grown on PEG gels with 0.8 μg/mL incubated with laminin for one, two, and three days under two media 
conditions:  Microsphere released GDNF (833 ng/mL incubation) in MNB media (Blue line, n=8), MNB media 
with no GDNF (Red line, n=14). 
*Note: All DRG’s in the control condition (No GDNF) had no extensions at Day 3.  Error bars shown, but error 
was zero due to uniformity of samples at this condition. 
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Conduits containing scaffolds labeled with Dylight-633 for easy visualization were implanted 
into rats traversing a severed sciatic nerve (Figure 4.12 C and D).  Scaffolds were 10 mm in length, 
with some variation, and with the fibrin plugs the total length of nerve gap was ~13 mm. 
Fluorescence images indicating the presence of non-degraded scaffold were compared to light images 
of the conduit to determine the percentage of each scaffold’s length that had degraded at each time 
point (Table 1). 
 
 
Figure 4.11. Conduit Fabrication Apparatus.  A. 1 mL pipette tip inserted securely into silicone tube 
plugged with glue. B. and C. 3D printed mold fit tightly around pipette tip and silicone tube, holding the tube in 
shape during centrifugation.  D. Apparatus is inserted into 15 mL conical vial and is ready for centrifugation of 
microspheres into a scaffold. 
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Most scaffolds composed of microspheres incubated less than 10 minutes were largely 
degraded after 1 week. There was no appreciable change in the length of the scaffolds composed of 
microspheres incubated 10 minutes, and were classified as 0% percent degraded, though small 
perturbations on the images would suggest that some degradation was occurring.  This was also true 
for two of the conduits with microspheres incubated below 10 minutes, 9 minute #2 and 9.5 minute 
#3.  What is most interesting about these two cases, in addition to their seeming inability to degrade 
like their counterparts created under the same conditions, is that it was these two conduits that 
resulted in tissue regeneration across the nerve gap.  Immunohistochemistry for the 3 cases of 
regenerated tissue is shown in Figure 4.13.  In the 9 and 9.5 minutes cases, a porous structure can be 
seen where the scaffold did not degrade.  DAPI showed cell growth throughout the tissue in all cases 
and S100 staining indicates the strong presence of Schwann cells in the porous regions.  Staining for 
neurofilaments (NF-160) was weak and did not indicate the presence of neurons.  In the conduits that 
 
Figure 4.12. Fully Formed Conduit Implantation.  A. Fully formed conduit: microsphere scaffold (blue) 
flanked by two fibrin plugs, glue plug still intact. B. Fully formed conduit, glue plug excised. Ready for 
implantation.  C. Implanted conduit traversing the severed sciatic nerve in a rat .  D. Fluorescent photograph of 
implanted conduit seen in C. (microspheres labeled with Dylight-633) 
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did incur an appreciable amount of degradation over their length, some differences were observed in 
their rates of degradation.  The conduits formed from 8 minute microspheres, especially, degraded 
faster than the other cases with longer incubation times. The conduits were also evaluated for any 
observed foreign body response, infection, or necrosis. None of the conduits were observed to elicit 
any of these negative biological reactions. 
 
 
Table 4.1. In vivo degradation of scaffolds.  Conduits containing fully-functionalized PEG microsphere 
scaffolds with gradients in GDNF were implanted in rats traversing a severed sciatic nerve.  Degradation of the 
scaffolds was evaluated using fluorescence microscopy.  Implants were evaluated for the presence of foreign 
body response, infection, and necrosis.  The conduits were also evaluated for whether or not tissue regenerated 
across the gap. 
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4.5 Conclusions 
 We have developed a process for creating nerve guidance conduits containing multi-
functionalized PEG microsphere scaffolds with concentration gradients in GDNF.  These 
microspheres have been engineered with multiple functionalities. They were made capable of heparin 
binding, to slow and control the rate of GDNF release, using a post-microsphere formation chemistry.  
In order to allow nerves to invade the conduit and extend successfully to the distal stump, we made 
 
Figure 4.13: IHC for Regenerated Tissue.  Fluorescent photomicrographs of sectioned tissue harvested from 
NGC’s at 8 weeks.  S100 (red) layered with DAPI (blue) staining over the whole length of the tissue is shown 
for the 3 instances of regeneration (occurring in different microsphere incubation time conditions).  Sample 
fluorescent photomicrographs at higher magnification (100X) of tissue stained for neurofilaments (green) 
shown for the 9.5 minute condition.  
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the microspheres degradable by plasmin, with tunable rates of degradation. Click cross-linking 
chemistries were incorporated to add stability to the scaffold. The cell adhesion protein, laminin, was 
bound to the microspheres to encourage cell growth.  The functionalities were combined and the 
GDNF concentration gradient making capability of these fully functionalized microspheres was 
confirmed. GDNF released from these microspheres was confirmed to be biologically active. Finally 
we developed methods for forming these scaffolds in silicone conduits using 3D printed plastic molds 
and added fibrin plugs to enhance scaffold stability. Finally, conduits were fabricated and implanted 
into rats traversing a severed sciatic nerve for a 55 day period to demonstrate that the conduit 
fabrication system was effective, that the scaffolds degrade in vivo, and that the conduits do not elicit 
any negative biological responses, such as infection or necrosis. 
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Chapter 5  
Conclusions  
5.1 Summary of Dissertation 
 Peripheral nerve injury is a critical area of healthcare in very real need of innovations to 
improve outcomes. Gradients in biological factors could prove very effective in treatments, but with 
current technologies creating and maintaining these gradients in biologically relevant system is 
problematic.  This work has sought to develop a treatment for PNI using gradients in GDNF formed 
by modular means utilizing PEG microspheres. In the first study this end pursued the formation of 
scaffolds with gradients in different types of microspheres based on their relative densities 
(buoyancies) and attaching proteins to the microspheres, by various means, allowing them to form 
gradients along with the microspheres. While successful in some respects, disadvantages led to the 
adoption of a different method in the second study.  Here, different batches of one type of 
microsphere (with one density) were loaded with GDNF or left empty.  The different batches were 
used to form layers within scaffolds, creating step gradients in GDNF that, when allowed to diffuse 
over the course of days, produced useful linear concentration profiles in GDNF along the length of 
the scaffold. This method being very successful and robust, the third study sought to develop the 
system further by adding various biological functionalities to the microspheres, thereby making the 
resulting scaffolds applicable for nerve regeneration. These functionalized microspheres were used to 
create NGC’s with linear concentration gradients in GNDF which were implanted into rats with 
severed sciatic nerves. 
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Chapter 2 presented the development of protein gradients created by harnessing density 
differences in batches of microspheres created under different conditions. The principle variable used 
to alter the density of the microspheres was the incubation time during microsphere formation.  By 
manipulating this to the greatest degree, microspheres were fabricated with a range of densities 
adequate for producing scaffolds with up to three distinct (sharp transitioning) tiers or up to five tiers 
with smooth transitions upon centrifugation of a mixed microsphere suspension. By manipulating 
another variable, temperature of microsphere formation, a two tier gradient with a smooth transition 
from one end to the other was produced.  Proteins, GDNF and BSA, were covalently bound to the 
microspheres such that the formation of gradients in microspheres resulted in the formation of a 
gradient in those proteins.  Heparin, which electrostatically binds many growth factors, was 
conjugated to the PEG so that proteins could be reversibly bound within the microsphere scaffold, 
preventing possible deformation of the protein and providing any present cells easier access to it. 
Through the heparin decorated microspheres, gradients in protamine and GDNF were created.  
Though the density mediated method of gradient making had many merits, difficulties led to 
the pursuit of a new method in Chapter 3.  It was found that the higher density microspheres rejected 
the GDNF to some extent, most likely do the high amounts of intra-microsphere cross-linking, which 
prevented swelling and caused the microspheres to become impenetrable by the GDNF. Since the 
lowest density microspheres, having the lowest cross-linking, would allow the highest infusion of 
GDNF, it was decided that strategy sequentially centrifuging microspheres of the same density (the 
lowest density possible) but with various concentrations of GDNF would be employed.  The 
downside of this strategy, implicitly, was that only sharp transition, step gradients could be made, 
allowing diffusion of the GDNF to produce more complex and useful gradients over time.  The 
concentration profiles of GDNF in these scaffolds were monitored over time, in some cases 12 days.  
Surprisingly, a simple two tier initial step gradient produced a very linear profile after only 1 day and 
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maintained that profile out to twelve days. Models based on Fickian diffusion mechanics were used to 
produce predictions of these profiles.  Again quite surprisingly, the experimental profiles proved 
much more linear than their predicted counterparts in many cases. Though the simple two tier model 
produced the best results, multi-tier formations were also fabricated to show the robustness of the 
technique. The heparin content of the microspheres was also altered to produce a step gradient in 
heparin, yielding various effects.   
With the success of the two tier, sequentially made gradient in GDNF, it was decided to 
modify the system to enhance biological relevance, shown in chapter 4.  Functionalities such as cell 
initiated degradability, inter-microsphere cross-linking, and cell adhesion would be needed if the 
scaffold was guide extending nerves. Before adding any new functionalities to the microspheres, 
issues with the heparin attachment method needed to be addressed. The chemistries used in chapters 2 
and 3 did not allow for a very high rate of heparin incorporation.  A new chemistry implementing an 
intermediate cysteine addition step was developed, yielding microspheres with up to 21 percent by 
weight heparin content, the highest of these being very small, even nano-scale. As with the previous 
chemistry, however, there was an issue with the heparin interfering with microsphere formation. 
Upon the addition of other functionalities, such as cell initiated degradability, the microspheres would 
not form unless the heparin content was lowered to around the same levels as the previous chemistry. 
Thus, the chemistry was further modified such that the heparin would be added post microsphere 
formation. Cell initiated degradability was added via the incorporation of a plasmin degradable 
peptide into the microspheres. Click chemistries were also integrated into the microspheres to 
enhance the stability of the scaffold, though with markedly less effect.  Attachment of laminin 
allowed for cell adhesion. The functionalities were combined, the gradient making capability was 
confirmed, and GDNF released from the microsphere was established to have retained its biological 
activity. Scaffolds made up of the functionalized microspheres were formed in silicone tubes by using 
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custom printed 3D plastic molds. Fibrin plugs were used to stabilize the scaffolds containing 
gradients in GDNF before implantation into rats, traversing a severed sciatic nerve, showing that the 
scaffolds degrade in vivo, incur no negative biological effects, such as infection or necrosis, and in 
some cases regenerate nerve tissue. 
 
5.2 Future Directions 
 The future for this method of fabricating NGC’s with gradients in neurotrophic factors 
through modular formation of scaffolds with PEG microspheres is quite promising.  In its current 
iteration, the method presented in chapter 4 should be tested in the rat sciatic nerve model more 
extensively.  Studies seeking to bridge shorter, less aggressive nerve gaps (less than 10 mm) should 
be explored to get more consistent regeneration before moving on to longer gaps.  After refinement 
and success in longer gaps, models with larger diameter nerves should also be considered, eventually 
scaling up to treatment defects applicable to humans.  One could envision a future commercially 
available kit with which these NGC’s containing gradients in GDNF can be produced by a hospital 
lab, ready for direct implantation into patients with peripheral nerve injury.  
 There are opportunities for improvement within the system that should be explored.  Most 
notably, the Click cross-linking functionally could be drastically improved upon, possibly eliminating 
the need to stabilize the scaffold with fibrin plugs in the conduit.  More of the Click agents will need 
to be incorporated into the microspheres or, at least, conjugated to them in a more efficient manner, 
decorating the outside of the microspheres rather than dispersing them throughout. The amount of 
Click agents was limited in this system mainly due to the intra-microsphere cross-linking it caused, 
hindering or even eliminating the plasmin degradability (which is crucial).  One way to mitigate this 
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cross-linking is to change the clickable PEG molecule from an 8-arm structure to a 4-arm or linear 
structure.  A linear PEG, especially, would completely eliminate the ability of the Click agents to 
coss-link the individual microspheres further, though they would provide fewer Clickable groups for 
inter-microsphere cross-linking. Currently, the Clickable PEG conjugates within the microspheres via 
reaction of amine groups on the Clickable PEG with vinyl sulfone groups on PEG8-VS. This Micheal-
type addition reaction will only occur efficiently under conditions found during microsphere 
fabrication.  Clickable PEG with thiol groups rather than amine groups could be useful because thiols 
react much more readily with vinyl sulfone groups, allowing for incorporation of Click agents at any 
point in the process, even post-microsphere formation.   
 Adding the Click cross-linking functionality post microsphere formation would have a number 
of benefits.  Because the Click agents would no longer be involved during microsphere formation, 
they would no longer affect plasmin degradability. This could yield added controllability to the 
kinetic of degradation as well as a wider range of degradation rates. Adding the Click cross-linking 
functionality post microsphere formation would also mean that the Click agents could be sequestered 
more on the outside of the microspheres, where they would be more available to react with their 
counterparts on other microspheres. This method could incur a problem, however. Since both heparin 
binding and cell adhesion already make use of this thiol/vinyl sulfone chemistry, the addition of yet 
another molecule attempting to bind in this way could very well cause interference.  There are a set 
amount of free vinyl sulfones within the microsphere, and considering that many will be sterically 
unavailable for attack by these large molecules, it is possible that there would not be enough vinyl 
sulfones to support all 3 of these participants.  As a result, the binding, and therefore the functionality, 
of one or more of these agents could be negatively affected.  Small alterations and fine tuning could 
certainly resolve this, should it occur.  
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 Other changes to improve the system could also be made. Adhesion molecules other than 
laminin could be employed to enhance the nerve cell adhesion. The plasmin degradable peptide used 
in this system could modified in a number of ways: making it longer or shorter to affect properties of 
the microspheres it forms, adding amino acids with different charges or specific functional groups 
capable some desirable reaction with the microspheres, or swapping it out for another degradable 
peptide entirely that has different kinetics or is sensitive to another enzyme. The initial gradient of 
GDNF can be changed to produce different profiles, or another neurotrophic factor such as NGF 
could be used in its stead. The makeup of the scaffold layers could be modified to affect how the 
nerve is allowed to extend through it.  For instance, a thin layer of non-degradable microspheres could 
be placed at the distal end of conduit to slow the progress of Schwann cells that might degrade the 
scaffold faster than what would be desirable.  
 With regards to the density mediated gradient formation system discussed in Chapter 2, there 
are certainly opportunities to expand upon that method.  While the method was not pursued further in 
this work due to the exclusion of GDNF in higher density microspheres as well as more general 
difficulties, the robustness of the system for creating seamless scaffolds with gradients in one step 
should not be discounted.  As discussed in chapter 4, the addition of heparin to the microspheres did 
hinder their formation and limit controllability to some extent, which wasn’t known at the time during 
the research conducted in chapter 2.  The new post-microsphere formation addition of heparin could 
greatly enhance the efficacy of the density mediated system. There are also many possibilities for the 
creation of other types of gradients and concentration profiles.  More combinations of incubation 
times and temperatures could be tested, and gradients in other factors such as porosity, adhesion 
molecules, degradability, structural stability, and heparin content could be engineered for a nearly 
limitless number of applications. One application discussed yet not pursued in this study was the use 
of the system for zero-order release of a drug or protein.  An exponential initial concentration profile 
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could be created by the 5 tier gradient, shown in Figure 2.6, or another set-up devised in the future (or 
possibly through the sequential method of chapter 3), and the drug or protein allowed to release out 
one end of the scaffold could have a near constant flux out that end over an extended period of time. 
One can envision this scaffold formed inside a tube, much like the NGC’s in chapter 4, and implanted 
subcutaneously to deliver a steady stream of drug to the patient’s blood stream, or even implanted at 
the site of a tumor to deliver a constant, localized dose of a therapeutic agent.  
 Another technology developed but not explored much further in the course of this work were 
the small, nano-scale, high heparin microspheres seen in chapter 4. At their size, around 500 nm, they 
would be suitable for injection into the bloodstream without fear of them causing an obstruction. The 
very large content of heparin, around 21 percent by weight, would also allow these microspheres to 
tightly, but reversibly, bind many different heparin binding molecules, delivering them to the patient 
in a very controlled manner and maintaining them in the blood stream for extended periods of time.  
While this was not pursued in this study, due to its lack of focus in the area of nerve regeneration and 
gradients, these small, high heparin microspheres may have many applications in the pharmaceutical 
industry.  
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